113 S2839 IS: Comprehensive Addiction and Recovery Act of 2014
U.S. Senate
2014-09-17
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
1.Short title; table of contents
(a)This Act may be cited as the
Comprehensive Addiction and Recovery Act of 2014
.(b)The table of contents for this Act is as follows:Sec. 1. Short title; table of contents.
Sec. 2. Findings.
Sec. 3. Definitions.
TITLE I—Prevention and education
Sec. 101. Development of best prescribing practices.
Sec. 102. National education campaign.
Sec. 103. Community-based coalition enhancement grants to address local drug crises.
TITLE II—Law enforcement and treatment
Sec. 201. Treatment alternative to incarceration programs.
Sec. 202. Law enforcement naloxone training and implementation pilot.
Sec. 203. Prescription drug take back expansion.
TITLE III—Treatment and recovery
Sec. 301. Evidence-based opioid and heroin treatment and interventions demonstration.
Sec. 302. Criminal justice medication assisted treatment and interventions demonstration.
Sec. 303. National youth recovery initiative.
Sec. 304. Building communities of recovery.
TITLE IV—Addressing collateral consequences
Sec. 401. Correctional education demonstration grant program.
Sec. 402. Revision of FAFSA form.
Sec. 403. National Task Force on Recovery and Collateral Consequences.
TITLE V—Addiction and treatment services for women, families, and veterans
Sec. 501. Authority to award competitive grants to address opioid and heroin abuse by pregnant and
parenting female offenders.
Sec. 502. Grants for family-based substance abuse treatment.
Sec. 503. Veterans' treatment courts.
TITLE VI—Incentivizing State comprehensive initiatives to address opioid and heroin abuse
Sec. 601. State demonstration grants for comprehensive opioid abuse response.
2.Congress finds the following:(1)The abuse of heroin and prescription painkillers is having a devastating effect on public health
and safety in communities across the United States. According to the
Centers for Disease Control and Prevention, drug overdose deaths now
surpass traffic crashes in the number of deaths caused by injury in the
United States. In 2011, an average of about 110 people in the United
States died from drug overdose every day.(2)Law enforcement officials and treatment experts throughout the country report that many
prescription opioid users have turned to heroin as a cheaper or more
easily obtained alternative to prescription drugs.(3)Opioid pain relievers are the most widely misused or abused controlled prescription drugs (commonly
referred to as CPDs
) and are involved in most CPD-related overdose incidents. According to the Drug Abuse Warning
Network (commonly known as DAWN
), the estimated number of emergency department visits involving nonmedical use of prescription
opiates or opioids increased by 112 percent, from 84,671 to 179,787,
between 2006 and 2010.(4)According to a report by the National Association of State Alcohol and Drug Abuse Directors
(commonly referred to as NASADAD
), 37 States reported an increase in admissions to treatment for
heroin use during the past 2 years, while admissions to treatment for
prescription opiates increased 500 percent from 2000 to 2012.(5)Addiction is a treatable disease. Discoveries in the science of addiction have led to advances in
the treatment of substance use disorders that help people stop abusing
drugs and prescription medications and resume their productive lives.(6)According to the Office of National Drug Control Policy (commonly referred to as ONDCP
), approximately 22,700,000 people in the United States
needed substance use disorder treatment in 2013, but only 2,500,000 people
received it.(7)Effective substance abuse prevention can yield major economic dividends. Every dollar invested in
prevention can lead to savings between $2 and $20.(8)According to the National Institute on Drug Abuse, when schools and communities properly implement
science-validated substance abuse prevention programs, alcohol, tobacco,
and illicit drug abuse are reduced. Such programs help teachers, parents,
and healthcare professionals shape the perceptions of youths about the
risks of drug abuse.(9)Diverting individuals with substance use disorders from criminal justice systems into
community-based treatment can save billions of dollars and prevent
sizeable numbers of crimes, arrests, and re-incarcerations over the course
of those individuals’ lives.(10)According to the Drug Enforcement Agency, more than 1,700 tons of expired, unwanted prescription
medications have been collected over the past 31/2 years, following the enactment of the Secure and Responsible Drug Disposal Act of 2010 (Public Law
111–273; 124 Stat. 2858).(11)Research shows that combining treatment medications with behavioral therapy is the best way to
ensure success for most patients. Treatment approaches must be tailored to
address the drug abuse patterns and drug-related medical, psychiatric, and
social problems of each individual. Different types of medications may be
useful at different stages of treatment to help a patient stop abusing
drugs, stay in treatment, and avoid relapse.(12)Research indicates that combating the epidemic of opioid abuse, including abuse of prescription
painkillers and, increasingly, heroin, requires a multi-pronged approach
that involves reducing drug diversion, expanding delivery of existing
treatments (including medication assisted treatments), expanding access to
overdose medications and interventions, and the development of new
medications for pain that can augment the existing treatment arsenal.3.In this Act—(1)the term Indian tribe has the meaning given the term in section 4 of the Indian Self-Determination and Education
Assistance Act (25 U.S.C. 450b);(2)the term medication assisted treatment means the use, for problems relating to heroin and other opioids, of medications approved by the
Food and Drug Administration in combination with
counseling and behavioral
therapies.;(3)the term ONDCP Recovery Branch means the Recovery Branch of the Office of National Drug Control Policy;(4)the term opioid means any drug having an addiction-forming or addiction-sustaining liability similar to morphine
or being capable of conversion into a drug having such addiction-forming
or addiction-sustaining liability;(5)the term Single State Authority for Substance Abuse has the meaning given the term in section 201(e) of the Second Chance Act of 2007 (42 U.S.C.
17521(e)); and(6)the term State means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico,
and any territory or possession of the United States.<enum>I</enum><header>Prevention and education</header><section id="idD936F9A6E50542FFAC7318E9BEB6C6AE"><enum>101.</enum><header>Development of best prescribing practices</header><subsection id="id881ca9e683094d2e9b8a95937866602a"><enum>(a)</enum><header>Inter-Agency task force</header><text>Not later than 120 days after the date of enactment of this Act, the Secretary of Health and Human
Services (referred to in this section as the <quote>Secretary</quote>), in cooperation with the Secretary of Veterans Affairs, the Secretary of Defense, and the
Administrator of the Drug Enforcement Administration, shall convene a Pain
Management Best Practices Inter-Agency Task Force (referred to in this
section as the <quote>task force</quote>).</text></subsection><subsection id="ide1b7d98100c84f299ed0793e4493f473"><enum>(b)</enum><header>Membership</header><text>The task force shall be comprised of—</text><paragraph id="id96a4a5d0c0c4440e91d2ae072def89a6"><enum>(1)</enum><text>representatives of—</text><subparagraph id="id63ba77a2fab54296ba2cd244a129459b"><enum>(A)</enum><text>the Department of Health and Human Services;</text></subparagraph><subparagraph id="id30a860ae6a3f4d799b57216b923b764f"><enum>(B)</enum><text>the Department of Veterans Affairs;</text></subparagraph><subparagraph id="id883fea548d064902bceabdb61b106c7e"><enum>(C)</enum><text>the Department of Defense;</text></subparagraph><subparagraph id="idbfabd7bea6924537bf06e2560bcd8ced"><enum>(D)</enum><text>the Drug Enforcement Administration;</text></subparagraph><subparagraph id="id33FAB373681A40A88BEDC43F1EA64F79"><enum>(E)</enum><text>the Centers for Disease Control and Prevention;</text></subparagraph><subparagraph id="id34944bbe7c3740b99a3b8ebe983229e8"><enum>(F)</enum><text>the Institute of Medicine; and</text></subparagraph><subparagraph id="id0FC5A7FC87634B44B89452A2FD45A377"><enum>(G)</enum><text>the Office of National Drug Control Policy;</text></subparagraph></paragraph><paragraph id="id97dd4a4078194b45923fd248378e1360"><enum>(2)</enum><text>the Director of the National Institutes of Health;</text></paragraph><paragraph id="id331ad552f44b432ca184d48b50ae96aa"><enum>(3)</enum><text>physicians, dentists, and non-physician prescribers;</text></paragraph><paragraph id="id7aec4a142394400eb35a4983c9435f03"><enum>(4)</enum><text>pharmacists;</text></paragraph><paragraph id="ide7cab242d036463ab06ea4175ac8f12f"><enum>(5)</enum><text>experts in the fields of pain research and addiction research;</text></paragraph><paragraph id="id7eef826ccef64ee98a14bbdba3529fc2"><enum>(6)</enum><text>representatives of—</text><subparagraph id="id5a8be76a6223466ca70e9914094b415b"><enum>(A)</enum><text>pain management professional organizations;</text></subparagraph><subparagraph id="id38e8368d803a465f9575f4dca9d43d2b"><enum>(B)</enum><text>the mental health treatment community;</text></subparagraph><subparagraph id="idE1DDCCBB6FDE43CFBC57AE78E6B336E6"><enum>(C)</enum><text>the addiction treatment community; and</text></subparagraph><subparagraph id="id2a3699d42ed548db8afc3cb3774ad6c5"><enum>(D)</enum><text>pain advocacy groups; and</text></subparagraph></paragraph><paragraph id="id6b422ddd97974843b8d40d3d5d2ae5a3"><enum>(7)</enum><text>other stakeholders, as the Secretary determines appropriate.</text></paragraph></subsection><subsection id="id951f074f9b5a4e4a9d4571ac78eeba76"><enum>(c)</enum><header>Duties</header><text>The task force shall—</text><paragraph id="idf29aaf1de4314e62acefd3fcd81cee62"><enum>(1)</enum><text>not later than 180 days after the date on which the task force is convened under subsection (a),
develop best practices
for pain management and prescribing pain medication, taking
into consideration—</text><subparagraph id="id3c11ac73ca8a4178a6780eb021f1dc84"><enum>(A)</enum><text>existing pain management research;</text></subparagraph><subparagraph id="idf00770c7b6fb4f1fbc15438d8f78bab0"><enum>(B)</enum><text>recommendations from relevant conferences; and</text></subparagraph><subparagraph id="id5ec67e4a74cd4837a07b175304711791"><enum>(C)</enum><text>ongoing efforts at the State and local levels and by medical professional organizations to develop
improved pain management strategies;</text></subparagraph></paragraph><paragraph id="id2d20b444675142eca5f4137d1093c5ac"><enum>(2)</enum><text>solicit and take into consideration public comment on the practices developed under paragraph (1),
amending such best practices if appropriate; and</text></paragraph><paragraph id="ida8d11ac4fef644179a55959027e99fd6"><enum>(3)</enum><text>develop a strategy for disseminating information about the best practices developed under
paragraphs (1) and (2) to prescribers, pharmacists, State medical boards,
and other parties, as the Secretary determines appropriate.</text></paragraph></subsection><subsection id="idbd793a6d253a4f9aacac40baf3412ff7"><enum>(d)</enum><header>Limitation</header><text>The task force shall not have rulemaking authority.</text></subsection><subsection id="id800b812e72c843f4a5a7136a4707a751"><enum>(e)</enum><header>Report</header><text>Not later than 270 days after the date on which the task force is convened under subsection (a),
the task force shall submit to Congress a report that includes—</text><paragraph id="idd937e81749be4901a8205168737431c4"><enum>(1)</enum><text>the strategy for disseminating best practices developed under subsection (c);</text></paragraph><paragraph id="id0745be40c985421ca469a7eb79d11ed9"><enum>(2)</enum><text>the results of a feasibility study on linking best practices developed under subsection (c) to
receiving and renewing registrations under section
303(f) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823(f)</external-xref>); and</text></paragraph><paragraph id="idc207aec9bba8453b9add074d6813b9cb"><enum>(3)</enum><text>recommendations on how to apply best practices developed under subsection (c) to improve
prescribing practices at medical
facilities, including medical facilities of the Veterans Health
Administration.</text></paragraph></subsection></section><section id="id8D03AED2CB184A17BC97AC897F1D76E3"><enum>102.</enum><header>National education campaign</header><subsection id="ida255ae1a177c43f0a0e5223fad43285f"><enum>(a)</enum><header>Definition</header><text>In this section, the term <term>eligible entity</term> means a State, unit of local government, or nonprofit organization.</text></subsection><subsection id="idf10473ea197a448e9ff611104b6ac40c"><enum>(b)</enum><header>Program authorized</header><text>The Attorney General, in coordination with the Secretary of Health and Human Services, the Director
of the Office of National Drug Control Policy, the Secretary of Education,
the Administrator of the Substance Abuse and Mental Health Services
Administration, and the Director of the Centers for Disease Control and
Prevention, may make grants to eligible entities to expand educational
efforts to prevent abuse of opioids, heroin, and other substances of
abuse, understand addiction as a chronic disease, and promote treatment
and recovery, including—</text><paragraph id="id9ba79a92e38347c186cdaf36c96c7b15"><enum>(1)</enum><text>parent and caretaker-focused prevention efforts, including—</text><subparagraph id="id02a5bb58a16e459caa0705617f5b3ca5"><enum>(A)</enum><text>the development of research-based community education online and social media materials with
an accompanying toolkit that can be
disseminated to communities to educate parents and other caretakers of
teens on—</text><clause id="id442d8c0df41745748cc974be0bffb17a"><enum>(i)</enum><text>how to educate teens about opioid and heroin abuse;</text></clause><clause id="id0bac77a53b944159b069f3ddbef26eff"><enum>(ii)</enum><text>how to intervene if a parent thinks or knows their teen is abusing opioids or heroin;</text></clause><clause id="id7d6ce66b0aed43d8ab517ff2f98e4d6f"><enum>(iii)</enum><text>signs of opioid or heroin overdose; and</text></clause><clause id="id287f91b27137416c861e2cd42011b340"><enum>(iv)</enum><text>the use of naloxone to prevent death from opioid or heroin overdose;</text></clause></subparagraph><subparagraph id="idc08b417d7da141688222a4f4f43ab450"><enum>(B)</enum><text>the development of detailed digital and print educational materials to accompany the online and
social media materials and
toolkit described in subparagraph (A);</text></subparagraph><subparagraph id="id0e58a3a05812498f8456645ea4279c1f"><enum>(C)</enum><text>the development and dissemination of public service announcements to—</text><clause id="idb2c3977967814c189b50a1279730c4e0"><enum>(i)</enum><text>raise awareness of heroin and opioid abuse among parents and other caretakers; and</text></clause><clause id="id147f0beb8a754a7294f5344634441d11"><enum>(ii)</enum><text>motivate parents and other caretakers to visit online educational materials on heroin and opioid
abuse; and</text></clause></subparagraph><subparagraph id="idba807c88f0bd404e95551606eba21f23"><enum>(D)</enum><text>the dissemination of educational materials to the media through—</text><clause id="idb44f5750a67c4f2683cc3ff9c1b6b5a1"><enum>(i)</enum><text>a town hall or panel discussion with experts;</text></clause><clause id="id1bdb714c7c244c708ae824e46c2caa50"><enum>(ii)</enum><text>a press release;</text></clause><clause id="id4ac3e488f25d4cb5999e5bad94f0f2e8"><enum>(iii)</enum><text>an online news release;</text></clause><clause id="id8dc3a858cfa5469e9b3e1ddf7554dbf0"><enum>(iv)</enum><text>a media tour; and</text></clause><clause id="id650d03db5cfa420ab8e791e4487f62cf"><enum>(v)</enum><text>sharable infographics;</text></clause></subparagraph></paragraph><paragraph id="idcc1b627a80914bb4a7237b2bfc406206"><enum>(2)</enum><text>prevention efforts focused on teenagers, college students, and college-age individuals, including—</text><subparagraph id="id96cfcca9226d4240b08adeeef14db79c"><enum>(A)</enum><text>the development of a national digital campaign; and</text></subparagraph><subparagraph id="iddb70aecf434349f6b71bb0f3d41a1b10"><enum>(B)</enum><text>the development of a community education toolkit for use by community coalitions;</text></subparagraph></paragraph><paragraph id="idb214b4080d02472889a1be8b09a36c65"><enum>(3)</enum><text>campaigns to inform individuals about available resources to aid in recovery from substance use
disorder;</text></paragraph><paragraph id="id8fde6e6bcc3545088388501f06635ac1"><enum>(4)</enum><text>encouragement of individuals in or seeking recovery from substance use disorder to enter the
health
care system; or</text></paragraph><paragraph id="id8284c2fea90b4b7c9f027569ee0ed7cb"><enum>(5)</enum><text>adult-focused awareness efforts, including efforts focused on older adults, relating to
prescription medication disposal, opioid and heroin abuse, signs of
overdose, and the use of naloxone for reversal.</text></paragraph></subsection><subsection id="id4ffc2f990a1a4fec922b22b4cd4ace8a"><enum>(c)</enum><header>Application</header><paragraph id="id8644f3096f4144c4912885a9835b7681"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney
General—</text><subparagraph id="id622C82D99833460B8B47D8EC3E761B02"><enum>(A)</enum><text>that meets the criteria under paragraph (2); and</text></subparagraph><subparagraph id="id068AD910D8254E459A2179A94041A469"><enum>(B)</enum><text>at such time, in such manner, and accompanied by such information
as the Attorney General may require.</text></subparagraph></paragraph><paragraph commented="no" id="idf88d6ecc41904eed9f86216c0ed01752"><enum>(2)</enum><header>Criteria</header><text>An eligible entity, in submitting an application under paragraph (1), shall—</text><subparagraph commented="no" id="id5C5000B62BFB421B825CF4A988E44974"><enum>(A)</enum><text>describe the evidence-based methodology and outcome measurements that will be used to evaluate the
program funded with a grant under this section;</text></subparagraph><subparagraph commented="no" id="id21839817EBBC47A1A2A7F996D81D4305"><enum>(B)</enum><text>specifically explain
how the measurements described in subparagraph (A) will provide valid
measures of the impact of the program described in subparagraph (A);</text></subparagraph><subparagraph commented="no" id="ide5f5a5909b4c448fb1ea08b76c3009a0"><enum>(C)</enum><text>describe how the program described in subparagraph (A) could be broadly replicated if demonstrated
to be effective;</text></subparagraph><subparagraph commented="no" id="id6431de206a7440559519d43c6932389c"><enum>(D)</enum><text>demonstrate that all planned services will be research-informed, which may include evidence-based
practices documented
in—</text><clause commented="no" id="idE32739252336465E9F83D2608B015669"><enum>(i)</enum><text>the report of the Institute of Medicine entitled <quote>Preventing Mental, Emotional, and
Behavioral Disorders Among Young People</quote>; or</text></clause><clause commented="no" id="id8B7F98FD7F6D4377A7EB1153E397AE1E"><enum>(ii)</enum><text>the National Registry of Effective Programs and
Practices (commonly referred to as <quote>NREPP</quote> of the Substance Abuse and Mental
Health Administration); and</text></clause></subparagraph><subparagraph commented="no" id="id808f2796bc514b07a951b2b858852b3f"><enum>(E)</enum><text>demonstrate that the eligible entity will effectively integrate and sustain the program described
in subparagraph (A) into curriculum or community outreach efforts.</text></subparagraph></paragraph></subsection><subsection id="id54e7318d6b2b41508890bb39bcb86749"><enum>(d)</enum><header>Use of funds</header><text>A grantee shall use a grant received under this section for expenses of educational efforts to—</text><paragraph id="id2cdf0716d721469f9e0236d30d4e49cd"><enum>(1)</enum><text>prevent abuse of opioids, heroin, alcohol, and other drugs; or</text></paragraph><paragraph id="id7beb4a02ff7346c1982903d6c81a2097"><enum>(2)</enum><text>promote treatment and recovery.</text></paragraph></subsection><subsection id="id8cd23e75aea74dde82f69806dc577b9d"><enum>(e)</enum><header>Duration</header><text>The Attorney General shall award grants under this section for a period not to exceed 2 years.</text></subsection><subsection id="idb09c470c4fd54b85b2948ccf3566cbcc"><enum>(f)</enum><header>Information sharing</header><text>The Office of the Attorney General, in coordination with the Substance Abuse and Mental Health
Services Administration
and the Department of Education, shall review existing evidence-based
programs and emerging practices and programs and provide information to
schools and communities about such
programs and practices.</text></subsection><subsection id="ida8a9c3454e2740f488f8fb85fe2c03cc"><enum>(g)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $2,500,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><section id="id9326323A8B074F67BCC4C684BB86937D"><enum>103.</enum><header>Community-based coalition enhancement grants to address local drug crises</header><subsection id="id396F8E39D1EF4523B84B051D53CD022D"><enum>(a)</enum><header>Definitions</header><text>In this section—</text><paragraph id="id9C1584B07D7046829F9B4F607A964CEE"><enum>(1)</enum><text>the term <term>Drug-Free Communities Act of 1997</term> means chapter 2 of subtitle A of title I of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1521 et
seq.);</text></paragraph><paragraph id="idE15E50AE19EB48C3BF32EC397C9163FE"><enum>(2)</enum><text>the term <term>eligible entity</term> means an organization that—</text><subparagraph id="id30DB5E486AD84FF1BBC354BF4A18C095"><enum>(A)</enum><text>on or before the date of submitting an application for a grant under this section, receives or has
received a grant under the
Drug-Free Communities Act of 1997; and</text></subparagraph><subparagraph id="idA56DF875BD4C46B59AB043777047AB6E"><enum>(B)</enum><text>has documented, using local data, rates of abuse of opioids at levels that
are—</text><clause id="id815f3013a6d54cc2a389caf6fc3e3bfe"><enum>(i)</enum><text>significantly higher than the national average as determined by the Attorney General (including
appropriate consideration of the Monitoring the Future Survey published by
the National Institute on Drug Abuse and the National Survey on Drug Use
and Health by the Substance Abuse and Mental Health Service
Administration); or</text></clause><clause id="idBCB3EE5C6A9B4A3E80152BE2D1203DDD"><enum>(ii)</enum><text>higher than the national average, as determined by the Attorney General (including appropriate
consideration of the surveys described in clause (i)), over a sustained
period of time; and</text></clause></subparagraph></paragraph><paragraph id="id40DF9D17E1304D57AB16C72522BB712F"><enum>(3)</enum><text>the term <term>local drug crisis</term> means, with respect to the area served by an eligible entity—</text><subparagraph id="idBA779A738452465FAA5979A9267E0988"><enum>(A)</enum><text>a sudden increase in the abuse of prescription medications, specifically opioids,
as documented by local data; or</text></subparagraph><subparagraph id="idE842A33C5E554545B43F9A492BCF6F2A"><enum>(B)</enum><text>the abuse of prescription medications, specifically opioids, that is significantly
higher than the national average, over a sustained period of time, as
documented by local data.</text></subparagraph></paragraph></subsection><subsection id="id599B413C153040BDB395B4550107BABB"><enum>(b)</enum><header>Program authorized</header><text>The Attorney General, in coordination with the Director of the Office of National Drug Control
Policy, may make grants to eligible
entities
to implement comprehensive community-wide strategies that
address local
drug
crises within the area served by the eligible entity.</text></subsection><subsection id="id50528646821A4DE8815D1F5A63DCBFB5"><enum>(c)</enum><header>Application</header><paragraph id="id512472877718464BB6CE6EE416634F7C"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney
General at such
time, in such manner, and accompanied by such information as the Attorney
General may require.</text></paragraph><paragraph id="id827DC084A1004F2EB2676C8A7F723D69"><enum>(2)</enum><header>Criteria</header><text>As part of an application for a grant under this section, the Attorney General shall require an
eligible entity to submit a detailed, comprehensive, multi-sector plan for
addressing the local drug crisis within the area served by the eligible
entity.</text></paragraph></subsection><subsection id="idD89D3A67245F426D80444007D042A8E2"><enum>(d)</enum><header>Use of funds</header><text>An eligible entity shall use a grant received under this section—</text><paragraph id="id1A53E88DA9F246E2ADA6ACC7DE255B21"><enum>(1)</enum><text>for programs designed to implement comprehensive community-wide prevention strategies to address
local drug crisis in the area served by the eligible entity, in accordance
with the plan submitted under subsection (c)(2); and</text></paragraph><paragraph id="idC7328ABDFA3D43FEB5ABDC94CAD378D8"><enum>(2)</enum><text>to obtain specialized training and technical assistance from the organization funded under section
4 of <external-xref legal-doc="public-law" parsable-cite="pl/107/82">Public Law 107–82</external-xref> (<external-xref legal-doc="usc" parsable-cite="usc/21/1521">21 U.S.C. 1521</external-xref> note).</text></paragraph></subsection><subsection id="idAD0C95C58B13472A8DE2A4D24B9DCE9D"><enum>(e)</enum><header>Grant amounts and duration</header><paragraph id="id925E555DD33A4A86835BB02C49845CE8"><enum>(1)</enum><header>Amounts</header><text>The Attorney General may not award a grant under this section for a fiscal year in an amount that
exceeds—</text><subparagraph id="id40EF747BFD00486486ED0E2F7B7D4DA1"><enum>(A)</enum><text>the amount of non-Federal funds raised by the eligible entity, including in-kind contributions, for
that fiscal year; or</text></subparagraph><subparagraph id="id3EA70BFFAF25436098EB46BDFBF5EBC4"><enum>(B)</enum><text>$75,000.</text></subparagraph></paragraph><paragraph id="idF8F8C0B370834C6881F71A268C2C3D86"><enum>(2)</enum><header>Duration</header><text>The Attorney General shall award grants under this section for a period not to exceed 4 years.</text></paragraph></subsection><subsection id="id4D92D8826A4742C8B8B8E830148FCB1F"><enum>(f)</enum><header>Supplement not supplant</header><text>An eligible entity shall use Federal funds received under this section only to supplement the funds
that would, in
the absence of those Federal funds, be made available from other Federal
and non-Federal sources for the activities described in this section, and
not to supplant those funds.</text></subsection><subsection id="idFCE5B00879B54E52ACEB590294C233F9"><enum>(g)</enum><header>Evaluation</header><text>A grant under this section shall be subject to the same evaluation requirements and procedures as
the evaluation requirements and procedures imposed on the recipient of a
grant under the Drug-Free
Communities Act of 1997.</text></subsection><subsection id="id726D0223AFFF4EC58034EF1AA05F2BE7"><enum>(h)</enum><header>Limitation on administrative expenses</header><text>Not more than 8 percent of the amounts made available pursuant to subsection (i) for a fiscal year
may be used by the Attorney General to pay for administrative expenses.</text></subsection><subsection id="id2B7CD68C09E5434EA09C67A206FC89E9"><enum>(i)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><enum>II</enum><header>Law enforcement and treatment</header><section id="id2AB2D757AF644C46BE49DAB667850FA9"><enum>201.</enum><header>Treatment alternative to incarceration programs</header><subsection id="id6077EB535BA5411FBE5038E31A34DAE0"><enum>(a)</enum><header>Definitions</header><text>In this section—</text><paragraph id="id4CF5B4F1EBEB49949507BA88207116AE"><enum>(1)</enum><text>the term <term>eligible entity</term> means a State, unit of local government, Indian tribe, or nonprofit organization; and</text></paragraph><paragraph id="id533915e692b24c16863ea065e5ec6274"><enum>(2)</enum><text>the term <term>eligible participant</term> means an individual who—</text><subparagraph id="id3C5F2253DBC54C6482741B0A73FAF8C2"><enum>(A)</enum><text>comes into contact with the criminal justice system or is charged with an
offense;</text></subparagraph><subparagraph id="id4513922785174B0589DDD6B4860AD765"><enum>(B)</enum><text>has a history of or a current—</text><clause id="id2A383D9A9F39423D94AD30497553DFB4"><enum>(i)</enum><text>substance use disorder;</text></clause><clause id="id4F4ABC79FD7341D384203EB18A86D7C4"><enum>(ii)</enum><text>mental
illness; or</text></clause><clause id="idE54E22A93EB74AABB35C081A3FC16732"><enum>(iii)</enum><text>co-occurring mental illness and substance use disorders; and</text></clause></subparagraph><subparagraph id="id84d203b6ccc7427d9a0597af2b763abf"><enum>(C)</enum><text>has been unanimously approved for participation in a program funded under this section by, as
applicable depending on the stage of the criminal justice process, the
relevant prosecuting attorney, defense attorney, probation or corrections
official, judge, or representative from the relevant mental health or
substance abuse agency.</text></subparagraph></paragraph></subsection><subsection id="id68E0B1B34DB04B209B6E4558C8EA7A8C"><enum>(b)</enum><header>Program authorized</header><text>The Attorney General may make grants to eligible entities to develop, implement, or expand a
treatment alternative to incarceration program for eligible participants,
including—</text><paragraph id="idDA9BB4F56785467796693EBD9440DA0E"><enum>(1)</enum><text>pre-booking treatment
alternative to incarceration programs, including—</text><subparagraph id="idBFCED1AC5C1F43CFB188339023839944"><enum>(A)</enum><text>law enforcement training on substance use disorders, mental illness, and co-occurring mental
illness and substance use disorders;</text></subparagraph><subparagraph id="id110ECFCBCF8B42318C11263AD4286CFC"><enum>(B)</enum><text>receiving centers as alternatives to incarceration of eligible participants;</text></subparagraph><subparagraph id="id8DC95F698D7445EF8DEE96AC78E901E5"><enum>(C)</enum><text>specialized response units for calls related to substance use disorders, mental illness, and
co-occurring mental illness and substance use disorders; and</text></subparagraph><subparagraph id="id5DC6916195DB42AFADF4DD35F178EFA7"><enum>(D)</enum><text>other arrest and pre-booking treatment alternative to incarceration models; and</text></subparagraph></paragraph><paragraph id="id164A02EF49EB475096833F2FB219DF05"><enum>(2)</enum><text>post-booking treatment
alternative to incarceration programs, including—</text><subparagraph id="idFA5BF7D5B1744FFAA1FE78D1757FF355"><enum>(A)</enum><text>specialized clinical case management;</text></subparagraph><subparagraph id="idF380A122E57346838B71F5C289D524EF"><enum>(B)</enum><text>pre-trial services related to substances use disorders, mental illness, and co-occurring mental
illness and substance use disorders;</text></subparagraph><subparagraph id="id1348EA6DA09D4F1C857CD181F93B4ABA"><enum>(C)</enum><text>prosecutor and defender based programs;</text></subparagraph><subparagraph id="idC2B16A1F1E4B4301888850E1BCFF7B80"><enum>(D)</enum><text>specialized probation;</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idF0EE62C40282459F8410227726B61F60"><enum>(E)</enum><text>treatment and rehabilitation programs; and</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id0E9A38E53D474375A847C36639CB1D67"><enum>(F)</enum><text>drug courts, DWI courts, and veterans treatment courts.</text></subparagraph></paragraph></subsection><subsection id="idf758d27dd6f9439a8742627cb9b1108a"><enum>(c)</enum><header>Application</header><paragraph id="id59358e84e96345ad8ec0d849df6770d0"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney
General—</text><subparagraph id="id47D848C679A146F7BAFEF118E1C546BC"><enum>(A)</enum><text>that meets the criteria under paragraph (2); and</text></subparagraph><subparagraph id="id19E839F300744E9F9CF3DB005DF24E67"><enum>(B)</enum><text>at such time, in such manner, and accompanied by such information
as the Attorney General may require.</text></subparagraph></paragraph><paragraph id="id56933251f4b74db4b68449898bd10b15"><enum>(2)</enum><header>Criteria</header><text>An eligible entity, in submitting an application under paragraph (1), shall—</text><subparagraph id="idce4b48bd0a744fb583786967d20b7f1a"><enum>(A)</enum><text>provide extensive evidence of collaboration with State and local government agencies overseeing
health, community corrections, courts, prosecution, substance abuse,
mental health, victims services, and employment services, and with local
law enforcement agencies;</text></subparagraph><subparagraph id="id7efc2c1c49bc44a5b756d43ac7418ac0"><enum>(B)</enum><text>demonstrate consultation with the Single State Authority for Substance Abuse;</text></subparagraph><subparagraph id="id66706CD410334D4C9A88014F5D16B153"><enum>(C)</enum><text>demonstrate that evidence-based treatment practices will be utilized; and</text></subparagraph><subparagraph id="id1DDFD1A44BC04E07AA874125AA944994"><enum>(D)</enum><text>demonstrate that evidenced-based screening and assessment tools will be utilized to place
participants in the treatment alternative to incarceration program.</text></subparagraph></paragraph></subsection><subsection id="id75302ca264a84dabbd3838e61f9a342d"><enum>(d)</enum><header>Requirements</header><text>Each eligible entity awarded a grant for a treatment alternative to incarceration program under
this section shall—</text><paragraph id="ide92a62adcf1a4b3898bf35a4a3c18e24"><enum>(1)</enum><text>determine the terms and conditions of participation in the program by eligible participants, taking
into consideration the collateral consequences of criminal conviction;</text></paragraph><paragraph id="idb399322ff301423f9a058f550033257c"><enum>(2)</enum><text>ensure that each substance abuse and mental health treatment component is licensed and qualified by
the relevant jurisdiction;</text></paragraph><paragraph id="id88a22e86ebbf4a2f99950de48ce7dc5c"><enum>(3)</enum><text>for programs described in subsection (b)(2), organize an enforcement unit comprised of
appropriately trained law enforcement professionals under the supervision
of the State,
Tribal, or local criminal justice agency involved, the duties of which
shall include—</text><subparagraph id="id0b37e70a5b494fc088f1e98e5e3e242c"><enum>(A)</enum><text>the verification of addresses and other contacts of each eligible participant who participates or
desires to participate in the program; and</text></subparagraph><subparagraph id="id629eeadded44495bab1213f8891d41d9"><enum>(B)</enum><text>if necessary, the location, apprehension, arrest, and return to court of an eligible participant in
the program who has absconded from the facility of a treatment provider or
has otherwise violated the terms and conditions of the program, consistent
with Federal and State confidentiality requirements;</text></subparagraph></paragraph><paragraph id="id0cc0a8b6b5044e7eb47bbfaa18a25beb"><enum>(4)</enum><text>notify the relevant criminal justice entity if any eligible participant in the program absconds
from the facility of the treatment provider or otherwise violates the
terms and conditions of the program, consistent with Federal and State
confidentiality requirements;</text></paragraph><paragraph id="id5e0edb67bdcd416684e212ab6114e282"><enum>(5)</enum><text>submit periodic reports on the progress of treatment of each eligible offender participating in the
program to the relevant State, Tribal, or local criminal justice agency;</text></paragraph><paragraph id="ida917071d0eb344469e8eabb47b3af561"><enum>(6)</enum><text>describe the evidence-based methodology and outcome measurements that will be used to evaluate the
program, and specifically explain
how such measurements will provide valid measures of the impact of the
program;
and</text></paragraph><paragraph id="id4fa904daeab444bc95d1f8dfae4d6c08"><enum>(7)</enum><text>describe how the program could be broadly replicated if demonstrated to be effective.</text></paragraph></subsection><subsection id="id23BEA7D6A2974A99B466B611BC7D1E88"><enum>(e)</enum><header>Use of funds</header><text>An eligible entity shall use a grant received under this section for expenses of a treatment
alternative to incarceration program, including—</text><paragraph id="id7F5FCFA6343E4F51896116B3AB34858C"><enum>(1)</enum><text>salaries, personnel costs, equipment costs, and other costs directly related to the operation of
the program, including the enforcement unit;</text></paragraph><paragraph id="idFBA28E2E7D48443799F233E5134739D9"><enum>(2)</enum><text>payments for treatment providers that are approved by the relevant State or Tribal jurisdiction and
licensed, if necessary, to provide needed treatment to eligible offenders
participating in the program, including aftercare supervision, vocational
training, education, and job placement; and</text></paragraph><paragraph id="id49299043B9044713AED8DA36C336F2FF"><enum>(3)</enum><text>payments to public and nonprofit private entities that are approved by the State or Tribal
jurisdiction and licensed, if necessary, to provide alcohol and drug
addiction treatment to eligible offenders participating in the program.</text></paragraph></subsection><subsection id="id862A767EC3F140269472C23F940C9019"><enum>(f)</enum><header>Supplement not supplant</header><text>An eligible entity shall use Federal funds received under this section only to supplement the funds
that would, in
the absence of those Federal funds, be made available from other Federal
and non-Federal sources for the activities described in this section, and
not to supplant those funds.</text></subsection><subsection id="id2C14A1980075461A8FEF128DB17D4DA1"><enum>(g)</enum><header>Geographic distribution</header><text>The Attorney General shall ensure that, to the extent practicable, the geographical distribution of
grants under
this section is equitable and includes a grant to an eligible entity in—</text><paragraph id="id3C4CD1815F2B4B8DB00235DE604976F2"><enum>(1)</enum><text>each State;</text></paragraph><paragraph id="id99044D0A7C6F4C9CA26BA50F08CAF0CE"><enum>(2)</enum><text>rural, suburban, and urban areas; and</text></paragraph><paragraph id="id6BEA353352674D5E959B7AE1282AF275"><enum>(3)</enum><text>Tribal jurisdictions.</text></paragraph></subsection><subsection id="id557115B51BA94402BCA237C0E9BF75DC"><enum>(h)</enum><header>Reports and evaluations</header><text>Each fiscal year, each recipient of a grant under this section during that fiscal year shall submit
to the Attorney General a report on the outcomes of activities
carried out using that grant in such form, containing such information,
and on such dates as the Attorney General shall specify.</text></subsection><subsection id="idF4A0998324E84FF0B55C294C16B1FE16"><enum>(i)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><section id="id1482A09A058F4E5D9936FD2E839098A5"><enum>202.</enum><header>Law enforcement naloxone training and implementation pilot</header><subsection id="idCA6405ABB0CE4A3CACA6BC49E60BD618"><enum>(a)</enum><header>Definition</header><text>In this section, the term <term>eligible entity</term> means a State, local, or tribal law enforcement agency.</text></subsection><subsection id="idF6536A131D404790B2E2D2EDFA6A9816"><enum>(b)</enum><header>Program authorized</header><text>The Attorney General, in coordination with the Secretary of Health and Human Services and the
Director of the Office of National Drug Control
Policy, may make grants to eligible entities to create a pilot law
enforcement program to prevent opioid and heroin overdose death.</text></subsection><subsection id="id4941514A50D74BA28A9C537AB9BBA79D"><enum>(c)</enum><header>Application</header><paragraph id="id4F09FBD1AF414133B20E4139DAA4CC4E"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney
General—</text><subparagraph id="id7C8295C6A3C749EF9CBBE8F2D6B83762"><enum>(A)</enum><text>that meets the criteria under paragraph (2); and</text></subparagraph><subparagraph id="id2637CB3C5CB94118990B3522EAE56BC1"><enum>(B)</enum><text>at such
time, in such manner, and accompanied by such information as the Attorney
General may require.</text></subparagraph></paragraph><paragraph commented="no" id="ide8a3820a1d6c405ba3f70b54237870c1"><enum>(2)</enum><header>Criteria</header><text>An eligible entity, in submitting an application under paragraph (1), shall—</text><subparagraph commented="no" id="id8ebbf810c4ab4630801dd49243b3ddef"><enum>(A)</enum><text>describe the evidence-based methodology and outcome measurements that will be used to evaluate the
program funded with a grant under this section, and specifically explain
how such measurements will provide valid measures of the impact of the
program;</text></subparagraph><subparagraph commented="no" id="idb1116cbd92274b01a87f33ce0d77e2d4"><enum>(B)</enum><text>describe how the program could be broadly replicated if demonstrated to be effective;</text></subparagraph><subparagraph commented="no" id="id236b11e78c6d4ea48c08087435913c81"><enum>(C)</enum><text>identify the governmental and community agencies that the program will coordinate; and</text></subparagraph><subparagraph commented="no" id="idd3ff80bdce56424da16bcf9fa18578b4"><enum>(D)</enum><text>describe how law enforcement agencies will coordinate with their corresponding
State substance abuse agency to identify protocols and resources that are
available to victims and families, including information on treatment and
recovery resources.</text></subparagraph></paragraph></subsection><subsection id="idbd5009a977654ab79671ab6adb19cc84"><enum>(d)</enum><header>Use of funds</header><text>An eligible entity shall use a grant received under this section to—</text><paragraph id="id2653e418bbe24105ac31fe81c7be835e"><enum>(1)</enum><text>make naloxone available to be carried and administered by law enforcement officers;</text></paragraph><paragraph id="id726b160115574a50832d1475d74fd691"><enum>(2)</enum><text>train and provide resources for law enforcement officers on carrying and administering naloxone for
the prevention of opioid and heroin overdose death; and</text></paragraph><paragraph id="id89865976f625498c894c9575f925bdb5"><enum>(3)</enum><text>establish processes, protocols, and mechanisms for referral to treatment.</text></paragraph></subsection><subsection id="id09986b0994a542d8b54047a7ea92a481"><enum>(e)</enum><header>Grant amounts and duration</header><paragraph id="idd82904ee390247f7a96c89d3b0882a3d"><enum>(1)</enum><header>Maximum amount</header><text>The Attorney General may not award a grant under this section in an amount that exceeds $500,000.</text></paragraph><paragraph id="idd2f9307c86f84511be1e24a3c77da94a"><enum>(2)</enum><header>Duration</header><text>The Attorney General shall award grants under this section for a period not to exceed 2 years.</text></paragraph></subsection><subsection id="ided905a870f784e87a1035dc0c7dbec89"><enum>(f)</enum><header>Technical assistance grants</header><text>The Attorney General shall make a grant for the purpose of providing
technical assistance and training on the use of naloxone to reverse
overdose deaths
and mechanisms for referral to treatment for an eligible entity receiving
a grant under this section.</text></subsection><subsection commented="no" display-inline="no-display-inline" id="id11C4BCB1E79D44E785641A1DE3D83DB4"><enum>(g)</enum><header>Evaluation</header><text>The Attorney General shall conduct an evaluation of grants made under this section to determine—</text><paragraph id="id0ebf3092bda04f28b1fc889e3037d813"><enum>(1)</enum><text>the number of officers equipped with naloxone for the prevention of fatal opioid and heroin
overdose;</text></paragraph><paragraph id="id3e2264f73003459ea8065aebaebafe2c"><enum>(2)</enum><text>the number of opioid and heroin overdoses reversed by officers receiving training and supplies of
naloxone through a grant received under this section;</text></paragraph><paragraph id="id148d18eb1fdd4e489e984bf34efb134a"><enum>(3)</enum><text>the number of calls for service related to opioid and heroin overdose;</text></paragraph><paragraph id="id1b3bce4c9b5841ba9e1a123d280ced74"><enum>(4)</enum><text>the extent to which overdose victims and families receive information about treatment services and
available data describing treatment admissions; and</text></paragraph><paragraph id="id53c05c67b218439d816d69c2ae982dee"><enum>(5)</enum><text>the research, training, and naloxone supply needs of law enforcement and first responder agencies,
including those agencies that are not receiving grants under this section.</text></paragraph></subsection><subsection id="idfa4f88ce757c4a5f8f3876e1266a148f"><enum>(h)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><section id="id13293FDEF829432BA7692B21B407D1A3"><enum>203.</enum><header>Prescription drug take back expansion</header><subsection id="id4B2F99536EDA46D494EB5E7F6D1FCC3F"><enum>(a)</enum><header>Definition</header><text>In this section, the term <term>eligible entity</term> means a State, local, or tribal law enforcement agency.</text></subsection><subsection id="idCFF827B629A44B7BB3B994CB1A033454"><enum>(b)</enum><header>Program authorized</header><text>The Attorney General, in coordination with the Administrator of the Drug Enforcement
Administration, the Secretary of Health and Human Services, and the
Director of the Office of National Drug Control
Policy, may make grants to eligible entities to expand or make available
disposal sites for
unwanted prescription medications.</text></subsection><subsection id="id3BEEB7CDD58E4213B6C1B8E0F6582516"><enum>(c)</enum><header>Application</header><paragraph id="idCD52C1BE72CE42EB839B928AA029FE37"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney
General—</text><subparagraph id="id83502151968542F8B1350ED6D4930E74"><enum>(A)</enum><text>that meets the criteria under paragraph (2); and</text></subparagraph><subparagraph id="idD8FD42BA94224F4F88E4A499A3AAEE14"><enum>(B)</enum><text>at such
time, in such manner, and accompanied by such information as the Attorney
General may require.</text></subparagraph></paragraph><paragraph commented="no" id="id84a73b11c17349699f89e1da398573d8"><enum>(2)</enum><header>Criteria</header><text>An eligible entity, in submitting an application under paragraph (1), shall—</text><subparagraph commented="no" id="id2471f5534cbc45e7a68ad07bd56551f0"><enum>(A)</enum><text>describe the evidence-based methodology and outcome measurements that will be used to evaluate the
program funded with a grant under this section, and specifically explain
how such measurements will provide valid measures of the impact of the
program;</text></subparagraph><subparagraph commented="no" id="id99b43f3b65924559b6fa7622af112a0d"><enum>(B)</enum><text>describe how the program could be broadly replicated if demonstrated to be effective; and</text></subparagraph><subparagraph commented="no" id="id4668b3f7b49549008b46d91930f0ac03"><enum>(C)</enum><text>identify the governmental and community agencies that the project will be coordinate.</text></subparagraph></paragraph></subsection><subsection id="id60BCEEF82EDB49E6BB9006940F3DB154"><enum>(d)</enum><header>Use of funds</header><text>An eligible entity shall use a grant received under this section for—</text><paragraph id="id30902883A464419895E07CC61E4917F3"><enum>(1)</enum><text>expenses of a prescription drug disposal site, including materials and resources;</text></paragraph><paragraph id="id8CFB96E622224392803359BEE0C52793"><enum>(2)</enum><text>implementing disposal procedures and processes;</text></paragraph><paragraph id="id810CB4DF68B64DE2BF7707BA9645852B"><enum>(3)</enum><text>implementing community education strategies, including community education materials and resources;</text></paragraph><paragraph id="idB48ACCB645804B1993B68CAADC7E58BF"><enum>(4)</enum><text>replicating a prescription drug take back initiative throughout multiple jurisdictions; and</text></paragraph><paragraph id="id0891A2F3D1A944028E958E9AA4D1502C"><enum>(5)</enum><text>training of law enforcement officers and other community participants.</text></paragraph></subsection><subsection id="id09FA3456CEAB456EA544F40BEB72ACAB"><enum>(e)</enum><header>Grant amounts and duration</header><paragraph id="id730E6830C17E42579F88F9072DC9D425"><enum>(1)</enum><header>Maximum amount</header><text>The Attorney General may not award a grant under this section in an amount that
exceeds $250,000.</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id294B11502F884A8683473FBC4A80DAFB"><enum>(2)</enum><header>Duration</header><text>The Attorney General shall award grants under this section for a period not to exceed 2 years.</text></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="id46C19EA3812946CAA406701DD2C8FA8F"><enum>(f)</enum><header>Technical assistance grant</header><text>The Attorney General shall make a grant to a national nonprofit organization to provide technical
assistance and training for an eligible entity receiving a grant under
this
section.</text></subsection><subsection commented="no" display-inline="no-display-inline" id="id59507E3471864E3B91FB49D5DF080AD4"><enum>(g)</enum><header>Evaluation</header><paragraph commented="no" display-inline="no-display-inline" id="id8CC9B89420A747D48755B0AFAB022526"><enum>(1)</enum><header>In general</header><text>The Attorney General shall make a grant for evaluation of the performance of each eligible entity
receiving a grant under this section.</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id08B2EBCD82AF41B1BB93CB34F9F25059"><enum>(2)</enum><header>Reports</header><text>Each fiscal year, the recipient of a grant under this subsection shall submit
to the Attorney General a report on the effectiveness of the prescription
drug take back program of each eligible entity receiving a grant under
this section.</text></paragraph></subsection><subsection id="id500D3E2FA9E746DFB84F000A8E663838"><enum>(h)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $2,500,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><enum>III</enum><header>Treatment and recovery</header><section id="id1FD456165A684A0EB08CEA2479254A97"><enum>301.</enum><header>Evidence-based opioid and heroin treatment and interventions demonstration</header><text display-inline="no-display-inline">Subpart 1 of part B of title V of the Public Health Service Act (42 U.S.C. 290bb
et seq.) is amended—</text><paragraph id="idB018D724CAE94EDEB397E2377A669A4C"><enum>(1)</enum><text display-inline="yes-display-inline">by redesignating section 514 (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-9">42 U.S.C. 290bb–9</external-xref>), as added by section 3632 of the Methamphetamine
Anti-Proliferation Act of 2000 (<external-xref legal-doc="public-law" parsable-cite="pl/106/310">Public Law 106–310</external-xref>; 114 Stat. 1236), as
section 514B; and</text></paragraph><paragraph id="idBBBDA29056BC443182E60242508C2E8B"><enum>(2)</enum><text display-inline="yes-display-inline">by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="id10815571E14B4B65854A0BA8ECDD24A6" style="OLC"><section id="id872615F581044222BDB8BD64F6F36DB0"><enum>514C.</enum><header>Evidence-based opioid and heroin treatment and interventions demonstration</header><subsection id="id2AD1B9DC401F4E9FBD7B7658D35FBD44"><enum>(a)</enum><header>Grants</header><paragraph id="id0F111805B6EF427FA909FD86461F71EB"><enum>(1)</enum><header>Authority to make grants</header><text>The Director of the Center for Substance Abuse Treatment (referred to in this section as the <quote>Director</quote>) may award grants to State substance abuse
agencies, units of local government, nonprofit organizations, and Indian
tribes or tribal organizations (as defined in section 4 of the Indian
Health Care Improvement Act (<external-xref legal-doc="usc" parsable-cite="usc/25/1603">25 U.S.C. 1603</external-xref>)) that have a high rate, or
have had
a rapid increase, in the use of heroin or other opioids, in order to
permit such entities to
expand activities, including an expansion in the availability of
medication assisted treatment, with respect to the treatment of
addiction in the specific geographical areas of such entities where there
is a rate or rapid increase in the use of heroin or other opioids.</text></paragraph><paragraph commented="no" id="idF2C4EE4AE8A448E9B415AE19625A59EA"><enum>(2)</enum><header>Recipients</header><text>The entities receiving grants under paragraph (1) shall be selected by the Director.</text></paragraph><paragraph id="id445AF07BA5864ECDB27EF770E4066A2E"><enum>(3)</enum><header>Nature of activities</header><text>The grant funds awarded under paragraph (1) shall be used for activities that are based on reliable
scientific evidence of
efficacy in the treatment of problems related to heroin or other opioids.</text></paragraph></subsection><subsection id="id0EE60C140D074FBC9F8F3A4EA4B5FF75"><enum>(b)</enum><header>Geographic distribution</header><text>The Director shall ensure that grants awarded under subsection (a) are distributed equitably among
the
various regions of the Nation and among rural, urban, and suburban areas
that are affected by the use of heroin or other opioids.</text></subsection><subsection id="id5A8BE46EF6514F329C63A95CD5DE5846"><enum>(c)</enum><header>Additional activities</header><text>The Director shall—</text><paragraph id="idC415F085E16C4DAEAF5A23B5314CE6B2"><enum>(1)</enum><text>evaluate the activities supported by grants awarded under subsection (a);</text></paragraph><paragraph id="id6E9B88F9771D4B099A5A2A883BB62A85"><enum>(2)</enum><text>disseminate widely such significant information derived from the evaluation as the Director
considers appropriate;</text></paragraph><paragraph id="id833E0CEEAA29422888844D64156B4183"><enum>(3)</enum><text>provide States, Indian tribes and tribal organizations, and providers with technical assistance in
connection with the
provision of treatment of problems related to heroin and other opioids;
and</text></paragraph><paragraph id="id2D82C3C042984B3D8406E40A2349927A"><enum>(4)</enum><text>fund only those applications that specifically support recovery services as a critical component of
the grant program.</text></paragraph></subsection><subsection commented="no" id="id747BEA33176D447B812017286F8815FE"><enum>(d)</enum><header>Definition</header><text>The term <term>medication assisted treatment</term> means the use, for problems relating to heroin and other opioids, of medications approved by the
Food and Drug Administration in combination with
counseling and behavioral
therapies.</text></subsection><subsection id="id136AF9309EA14968ACC9B1ACE321CF2D"><enum>(e)</enum><header>Authorization of appropriations</header><paragraph id="id421F6586744046439A4562BAB89E2F55"><enum>(1)</enum><header>In general</header><text>There are authorized to be appropriated to carry out this section $10,000,000 for fiscal year 2016
and such sums as may be necessary for each of fiscal years 2016 through
2020.</text></paragraph><paragraph id="idBD0DEB93F3F54E1E97364F72546DC171"><enum>(2)</enum><header>Use of certain funds</header><text>Of the funds appropriated to carry out this section in any fiscal year, the lesser of 5 percent of
such funds or $1,000,000 shall be available to the Director for purposes
of carrying out subsection (c).</text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section id="iddb5eff5a06f548b4b7bb903927da3282"><enum>302.</enum><header>Criminal justice medication assisted treatment and interventions demonstration</header><subsection id="id0A867C93F394407E857BF9B98DD2DAB3"><enum>(a)</enum><header>Definitions</header><text>In this section—</text><paragraph id="id4CC3542D895643AB8D72B72599050849"><enum>(1)</enum><text>the term <term>criminal justice agency</term> means a State, local, or tribal—</text><subparagraph id="id28CB0159E9BA41129572FE8C66CA16C9"><enum>(A)</enum><text>court;</text></subparagraph><subparagraph id="idF35967070FA54868AEF10F1F2A114E31"><enum>(B)</enum><text>prison;</text></subparagraph><subparagraph id="idE4304D3C77EB4BDF9EAE56E6C890E737"><enum>(C)</enum><text>jail; or</text></subparagraph><subparagraph id="id927BFBA7136E4383A67601967173F2E0"><enum>(D)</enum><text>other agency that performs the administration of criminal justice, including prosecution, pretrial
services, and community supervision; and</text></subparagraph></paragraph><paragraph id="idEC64897294074C5B90423BCE0698C2CE"><enum>(2)</enum><text>the term <term>eligible entity</term> means a State, unit of local government, or Indian tribe.</text></paragraph></subsection><subsection id="idC716D33ECA3F471494C5A075425CBE4D"><enum>(b)</enum><header>Program authorized</header><text>The Attorney General, in coordination with the Secretary of Health and Human Services and the
Director of the Office of National Drug Control
Policy, may make grants to eligible entities to implement medication
assisted treatment programs <italic></italic>through criminal justice agencies.</text></subsection><subsection id="id318EAA947D064CAAA7DE5A9A03775222"><enum>(c)</enum><header>Application</header><paragraph id="id361227407ADF412F958EF2397172ED5E"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney
General—</text><subparagraph id="id8869A8798FF842DE87D2AEE4E36E5774"><enum>(A)</enum><text>that meets the criteria under paragraph (2); and</text></subparagraph><subparagraph id="idF2CA777C3F9E43FCA0DF80F3FB732C42"><enum>(B)</enum><text>at such
time, in such manner, and accompanied by such information as the Attorney
General may require.</text></subparagraph></paragraph><paragraph id="id13ce16ad502c483bb2b58332dc0d463c"><enum>(2)</enum><header>Criteria</header><text>An eligible entity, in submitting an application under paragraph (1), shall—</text><subparagraph id="id4269E10690B846FF96381F1AFFEF6437"><enum>(A)</enum><text>certify that each medication assisted treatment program funded with a grant under this section has
been developed in consultation with the Single State Authority for
Substance Abuse; and</text></subparagraph><subparagraph id="idF818ACA46C11486F9C70D6090D00AA66"><enum>(B)</enum><text>describe how data will be
collected and analyzed to determine the effectiveness of the program
described in subparagraph (A).</text></subparagraph></paragraph></subsection><subsection id="id7abcaae7d2d8411f9f8465c575c8d25c"><enum>(d)</enum><header>Use of funds</header><text>An eligible entity shall use a grant received under this section for expenses of—</text><paragraph id="id46629356d1864558be3d4513d1bbe611"><enum>(1)</enum><text>a medication assisted treatment program, including the expenses of prescribing medications
recognized by the Food and Drug Administration for opioid treatment in
conjunction with psychological and behavioral therapy;</text></paragraph><paragraph id="idcc09d1900294430cb002bf4fd5d4c4b3"><enum>(2)</enum><text>training criminal justice agency personnel and treatment providers on medication assisted
treatment;</text></paragraph><paragraph id="id94c7a3ab26f346abb1909ad4d55a5dc6"><enum>(3)</enum><text>cross-training personnel providing behavioral health and health services, administration of
medicines, and other administrative expenses, including required reports;
and</text></paragraph><paragraph id="id71ee7fd9ed3a49a083ae29c6140a7816"><enum>(4)</enum><text>the provision of recovery coaches who are responsible for providing mentorship and transition plans
to individuals reentering society following incarceration or alternatives
to incarceration.</text></paragraph></subsection><subsection id="idD574B6649482400F9C224884AD7B3CBD"><enum>(e)</enum><header>Grant amounts and duration</header><paragraph id="idBA7B9F359B1242439B2891285ACA677C"><enum>(1)</enum><header>Maximum amount</header><text>The Attorney General may not award a grant under this section in an amount that
exceeds $750,000.</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id0C75A49516034F02BEE9DB514450BB1D"><enum>(2)</enum><header>Duration</header><text>The Attorney General shall award grants under this section for a period not to exceed 2 years.</text></paragraph></subsection><subsection id="id62009a5a2a804a3b96b2c6d9a907c7c5"><enum>(f)</enum><header>Technical assistance</header><text>The Attorney General, in coordination with the Director of the National Institute on Drug Abuse and
the Secretary of Health and Human Services, shall provide technical
assistance and training for an eligible entity receiving a grant under
this section.</text></subsection><subsection id="id4e6949f689ad4153964aaf895ebfff26"><enum>(g)</enum><header>Reports</header><paragraph id="id72ea10b29a434e948fc4e87c334667bc"><enum>(1)</enum><header>In general</header><text>An eligible entity receiving a grant under this subsection shall submit a report to the Attorney
General on the outcomes of each grant received under this section for
individuals receiving medication assisted treatment, based on—</text><subparagraph id="idb45813e7867d445abc20f3a1b41c7976"><enum>(A)</enum><text>the recidivism of the individuals;</text></subparagraph><subparagraph id="idb28b5a2724134c54aaed23340663766b"><enum>(B)</enum><text>the treatment outcomes of the individuals, including maintaining abstinence from illegal,
unauthorized, and unprescribed opioids and heroin;</text></subparagraph><subparagraph id="id2d57885ecfc04d1988aa05c6dc6defdf"><enum>(C)</enum><text>the housing status of the individuals; and</text></subparagraph><subparagraph id="id5d080aff18f143a3b02f242809099612"><enum>(D)</enum><text>the employment status of the individuals.</text></subparagraph></paragraph><paragraph id="idfb692ae02d0e41d88818ef93dc6c9d51"><enum>(2)</enum><header>Contents and timing</header><text>Each report described in paragraph (1) shall be submitted annually in such form, containing such
information, and on such dates as the Attorney General shall specify.</text></paragraph></subsection><subsection id="id600904B58B014CD9B57927117DA41CF8"><enum>(h)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><section id="id3e9001177ec14f8a8476b5baf8996a7b"><enum>303.</enum><header>National youth recovery initiative</header><subsection id="idf57b5864822b404199bdeb8bee85937f"><enum>(a)</enum><header>Definitions</header><text>In this section:</text><paragraph id="ida8ddd14241864d5282102c7d4f568b4b"><enum>(1)</enum><header>Eligible entity</header><text>The term <term>eligible entity</term> means—</text><subparagraph id="id8a4cb866d4a64fe0bc61b64ecd2fe553"><enum>(A)</enum><text>a high school that has been accredited as a recovery high school by the Association of Recovery
High Schools;</text></subparagraph><subparagraph id="idD0D7F0F221C247E0A9AEB3709552CABB"><enum>(B)</enum><text>an accredited high school that is seeking to establish or expand recovery support services;</text></subparagraph><subparagraph id="idb5d47cb0e1b246cf9acc5a9d0fcaeff7"><enum>(C)</enum><text>an institution of higher education;</text></subparagraph><subparagraph id="id638d697b6db54b4cb84a015ad6de5254"><enum>(D)</enum><text>a recovery program at a nonprofit collegiate institution; or</text></subparagraph><subparagraph id="idd2457b3b5ce64ae19caf298dfa2c5885"><enum>(E)</enum><text>a nonprofit organization.</text></subparagraph></paragraph><paragraph id="idc0c570eff56144349d5ba7ef6af76523"><enum>(2)</enum><header>Institution of higher education</header><text>The term <term>institution of higher education</term> has the meaning given the term in section 101 of the Higher Education Act of 1965 (20 U.S.C.
1001).</text></paragraph><paragraph id="ida1897a6241df475ebd220381df5a294b"><enum>(3)</enum><header>Recovery program</header><text>The term <term>recovery program</term>—</text><subparagraph id="idf371272007b54574990ef2bea3b88000"><enum>(A)</enum><text>means a program to help individuals who are recovering from substance use disorders to initiate,
stabilize, and maintain healthy and productive lives in the community; and</text></subparagraph><subparagraph id="id5b6f69b611eb426b9f1bf4cbe1a8d6cb"><enum>(B)</enum><text>includes peer-to-peer support and communal activities to build recovery skills and supportive
social networks.</text></subparagraph></paragraph></subsection><subsection id="id84b58cfcb60c493dbb2c55aa05be3760"><enum>(b)</enum><header>Grants authorized</header><text>The ONDCP Recovery Branch, in consultation with the Secretary of Education, may award grants to
eligible
entities to enable the entities to—</text><paragraph id="id60e10a9fa98344c2a4075ae0e023b3d8"><enum>(1)</enum><text>provide substance use recovery support services to young people in high school and enrolled in
institutions of higher education;</text></paragraph><paragraph id="idc64ce78b24e548de9915a811eb4974d3"><enum>(2)</enum><text>help build communities of support for young people in recovery through a spectrum of activities
such as counseling and healthy and wellness-oriented social activities;
and</text></paragraph><paragraph id="id16f740567e684d54a37aa28f3cad1297"><enum>(3)</enum><text>encourage initiatives designed to help young people achieve and sustain recovery from substance
use disorders.</text></paragraph></subsection><subsection id="idb37fb09090d046a1909fc1ca4719eb56"><enum>(c)</enum><header>Use of funds</header><text>Grants awarded under subsection (b) may be used for activities to develop, support, and maintain
youth recovery support services, including—</text><paragraph id="id100ec864e3804620be399f7bd7d5118d"><enum>(1)</enum><text>the development and maintenance of a dedicated physical space for recovery programs;</text></paragraph><paragraph id="id7929dd1347a4487eb27974fd2e5d5347"><enum>(2)</enum><text>dedicated staff for the provision of recovery programs;</text></paragraph><paragraph id="id769a9b7b1fa147588bdef1641f2ad692"><enum>(3)</enum><text>healthy and wellness-oriented social activities and community engagement;</text></paragraph><paragraph id="id62ced3b46f4b40adb248d8231829f620"><enum>(4)</enum><text>establishment of recovery high schools;</text></paragraph><paragraph id="idcbe6695af3b04bcf8d70717437476b49"><enum>(5)</enum><text>coordination of recovery programs with—</text><subparagraph id="iddf548edf3ae5442e9e4306fc3565ca51"><enum>(A)</enum><text>substance use disorder treatment programs and systems;</text></subparagraph><subparagraph id="id5a9d95771b8e41789727a7623305cd0b"><enum>(B)</enum><text>primary care providers;</text></subparagraph><subparagraph id="id3cffa84bbe224d38842d3d1c1d4077d3"><enum>(C)</enum><text>the criminal justice system, including the juvenile justice system;</text></subparagraph><subparagraph id="idd7848abb98954c01877b1f57c97ec39d"><enum>(D)</enum><text>employers;</text></subparagraph><subparagraph id="id1ceb6f43f1d34c32b86499591d5f2cb3"><enum>(E)</enum><text>housing services;</text></subparagraph><subparagraph id="id56d91721b4ba4654b54d6153e25e8224"><enum>(F)</enum><text>child welfare services;</text></subparagraph><subparagraph id="id642F1908385042FBBF4CDBE9DDC23B02"><enum>(G)</enum><text>institutions of secondary higher education and institutions of higher education; and</text></subparagraph><subparagraph id="id2ff2421559f0460e985e0ba3359315be"><enum>(H)</enum><text>other programs or services related to the welfare of an individual in recovery from a substance use
disorder;</text></subparagraph></paragraph><paragraph id="id534a4bd64cc54a09bac70e0d8683f524"><enum>(6)</enum><text>the development of peer-to-peer support programs or services; and</text></paragraph><paragraph id="id7cc505b0736a411aa8325e74c302dd41"><enum>(7)</enum><text>additional activities that help youths and young adults to achieve recovery from substance use
disorders.</text></paragraph></subsection><subsection id="id162ab3f179804adbbe8749cdbf64286f"><enum>(d)</enum><header>Resource center</header><text>The ONDCP Recovery Branch shall establish a resource center to provide technical support to
recipients of grants under this section.</text></subsection><subsection id="idf32dc1991b6346fc9d80fa5f6089cf69"><enum>(e)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $3,000,000 for fiscal year
2016 and each of the 5 succeeding fiscal years.</text></subsection></section><section id="id30c88a633d724f4cb6ae5cf3506fd5f3"><enum>304.</enum><header>Building communities of recovery</header><subsection id="iddb6710a339dc462b943070d6eff86bbc"><enum>(a)</enum><header>Definition</header><text>In this section, the term <term>recovery community organization</term> means an independent nonprofit organization that—</text><paragraph id="idfa74e44112594d1cbff0ed112354fb0c"><enum>(1)</enum><text>mobilizes resources within and outside of the recovery community to increase the prevalence and
quality of long-term recovery from substance use disorders; and</text></paragraph><paragraph id="idb6ea836da8b247cfb7de9ead97f77313"><enum>(2)</enum><text>is wholly or principally governed by people in recovery for substance use disorders who reflect the
community served.</text></paragraph></subsection><subsection id="id0ff6d62db85e485c91637646794cdb13"><enum>(b)</enum><header>Grants authorized</header><text>The ONDCP Recovery Branch, in consultation with the Substance Abuse and Mental Health Services
Administration, may award grants to recovery community organizations to
enable such organizations to develop, expand, and enhance
recovery services.</text></subsection><subsection id="id5db698849fb44e73b811df252c124793"><enum>(c)</enum><header>Maximum grant amount</header><text>The ONDCP Recovery Branch may not award a grant under this section in an amount that exceeds
$200,000.</text></subsection><subsection id="idB00891D7CEB04FDFAF895E6EA2559970"><enum>(d)</enum><header>Federal share</header><text>The Federal share of the costs of a program funded by a grant under this section may not exceed 50
percent.</text></subsection><subsection id="idCB08367A351A474FB8769B414B0B2B51"><enum>(e)</enum><header>Use of funds</header><text>Grants awarded under subsection (b)—</text><paragraph id="id9cd7d40f59604a41b25ad2c68ac903f3"><enum>(1)</enum><text>shall be used to develop, expand, and enhance community and statewide recovery support services;
and</text></paragraph><paragraph id="id8444c06b28ae4fa6952928fb150e126b"><enum>(2)</enum><text>may be used to—</text><subparagraph id="idccef6bb1ed9f41c686c4d3bd00503e49"><enum>(A)</enum><text>advocate for individuals in recovery from substance use disorders;</text></subparagraph><subparagraph id="id2f618f29ba304d4a97cd354749c10159"><enum>(B)</enum><text>build connections between recovery networks, between recovery community organizations, and with
other
recovery support services, including—</text><clause id="id6d1ae719787d464a80579e46771bf30a"><enum>(i)</enum><text>substance use disorder treatment programs and systems;</text></clause><clause id="idaeaac4564e0b48dc94166abc0eaaa007"><enum>(ii)</enum><text>primary care providers;</text></clause><clause id="id8f947a0beb8642f9ac67eceecf7265de"><enum>(iii)</enum><text>the criminal justice system;</text></clause><clause id="id3717c9339c3947afbd374b00d272edd6"><enum>(iv)</enum><text>employers;</text></clause><clause id="id806d4222c8c1420884a5d984d39ce0d4"><enum>(v)</enum><text>housing services;</text></clause><clause id="idcb93227d13c44b828d51746d03a76ac7"><enum>(vi)</enum><text>child welfare agencies; and</text></clause><clause id="idbfb985b4bb1c46beb2cec320ce017a37"><enum>(vii)</enum><text>other recovery support services that facilitate recovery from substance use disorders;</text></clause></subparagraph><subparagraph id="id647fce54214f4ca598921f621240d4d4"><enum>(C)</enum><text>reduce the stigma associated with substance use disorders;</text></subparagraph><subparagraph id="idb8c2f1c02f0f4fe3a3121240213d9664"><enum>(D)</enum><text>conduct public education and outreach on issues relating to substance use disorders and recovery,
including—</text><clause id="id337d7fd5658c4894abdaa89a5eb80605"><enum>(i)</enum><text>how to identify the signs of addiction;</text></clause><clause id="idb7afc259dc5342afa8651ccc741de00e"><enum>(ii)</enum><text>the resources that are available for individuals struggling with addiction;</text></clause><clause id="id7348b1a10a1c4d52803800f2190c4b52"><enum>(iii)</enum><text>the resources that are available to help support individuals in recovery; and</text></clause><clause id="ide914344b58c1467496254f49111d4ab2"><enum>(iv)</enum><text>information on the medical consequences of substance use disorders, including neonatal abstinence
syndrome and potential infection with human immunodeficiency virus and
viral hepatitis; and</text></clause></subparagraph><subparagraph id="id9b60251f9158472eb7e244326de6cd10"><enum>(E)</enum><text>carry out other activities that strengthen the network of community support for individuals in
recovery.</text></subparagraph></paragraph></subsection><subsection id="id7fcde41112d64d95aa7d6d06859b8721"><enum>(f)</enum><header>Resource center</header><text display-inline="yes-display-inline">The ONDCP Recovery Branch shall establish a resource center to
provide technical assistance to recipients of grants under this section
and to provide information to individuals seeking to support people in
recovery from substance use disorders.</text></subsection><subsection id="idc30abea36e9d4b9185d3585d590de1cc"><enum>(g)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated to carry out this section $50,700,000 in fiscal year
2016
and each of the 3 succeeding fiscal years.</text></subsection></section><enum>IV</enum><header>Addressing collateral consequences</header><section id="idbd45e74822624de7b82143ffcccaa737"><enum>401.</enum><header>Correctional education
demonstration grant program</header><text display-inline="no-display-inline">Title I of the Omnibus Crime Control and Safe Streets Act of 1968 (<external-xref legal-doc="usc" parsable-cite="usc/42/3711">42 U.S.C. 3711 et seq.</external-xref>) is
amended—</text><paragraph id="id961adfcab97e4c8ebc9fbc32321ea5cc"><enum>(1)</enum><text>by redesignating part KK as part LL; and</text></paragraph><paragraph id="idd22a2a90edce4fd9bd02cc27e735c118"><enum>(2)</enum><text>by inserting before part LL, as redesignated, the following:</text><quoted-block display-inline="no-display-inline" id="id08b50c262a1b42da9083c7ad7e77d679" style="OLC"><part id="idf762bd165bd249afb259641c696b7dfb"><enum>KK<?LEXA-Enum KK?></enum><header>Correctional education demonstration grant program</header><section id="id57667d57c5024bc58a448b09bee7bc39"><enum>3001.</enum><header>Correctional education demonstration grant program</header><subsection id="id7749312a771c4e14bc66e3495d05e102"><enum>(a)</enum><header>Definition</header><text>In this section, the term <term>eligible entity</term> means a State, unit of local government, nonprofit organization, or Indian Tribe.</text></subsection><subsection id="id37851F8AC81842F0BB2CA29ADC99C1A1"><enum>(b)</enum><header>Grant program authorized</header><text>The Attorney General may make grants of not more than $750,000 to eligible entities to design,
implement,
and expand educational programs for offenders in prisons, jails, and
juvenile facilities, including to pay for—</text><paragraph id="id52ab4ce6a34d4e8cbbe274188336867f"><enum>(1)</enum><text>basic education, secondary level academic education, high school equivalency examination
preparation, career technical education, and English as a second language
instruction at the basic,
secondary, or post-secondary levels, for adult and juvenile populations;</text></paragraph><paragraph id="id551e12405a0d4d71af3051736a441bbd"><enum>(2)</enum><text>screening and assessment of inmates to assess education level, needs, occupational interest or
aptitude, risk level, and other needs, and case management services;</text></paragraph><paragraph id="idef00be28335646bb9a325d5c72e83d8e"><enum>(3)</enum><text>hiring and training of instructors and aides, reimbursement of non-corrections staff and experts,
reimbursement of stipends paid to inmate tutors or aides, and the costs
of training inmate tutors and aides;</text></paragraph><paragraph id="id15de3cdcca854f85b3c5683951c9481e"><enum>(4)</enum><text>instructional supplies and equipment, including occupational program supplies and equipment to the
extent that the supplies and equipment are used for instructional
purposes;</text></paragraph><paragraph id="id81f574cd6dda4203abe5becdde77b856"><enum>(5)</enum><text>partnerships and agreements with community colleges, universities, and career technology education
program providers, including tuition payments;</text></paragraph><paragraph id="idb9adc8b861424ca7be09030991ef81b9"><enum>(6)</enum><text>certification programs providing recognized high school equivalency certificates and industry
recognized credentials; and</text></paragraph><paragraph id="id02e498ae46c24944a8025d3768966e8b"><enum>(7)</enum><text>technology solutions to—</text><subparagraph id="id6E7CE91F95B3492A95054812E2C57E78"><enum>(A)</enum><text>meet the instructional, assessment, and information needs of correctional
populations; and</text></subparagraph><subparagraph id="idA68375E5E78A40CD8D223F6993541735"><enum>(B)</enum><text>facilitate the continued participation of incarcerated
students in community-based education programs after the students are
released from incarceration.</text></subparagraph></paragraph></subsection><subsection id="id4c7b4fe4a44c411c94ad4f4426d2a66c"><enum>(c)</enum><header>Application</header><text>An eligible entity desiring a grant under this section shall submit to the Attorney General an
application in such form and
manner, at such time, and accompanied by such information as the Attorney
General specifies.</text></subsection><subsection id="id65d8540b94f34c54b7a522cafd398fa7"><enum>(d)</enum><header>Priority considerations</header><text>In awarding grants under this section, the Attorney General shall give priority to applicants that—</text><paragraph id="ida5c8708492d647f89f296070caf63f2b"><enum>(1)</enum><text>assess the level of risk and need of inmates, including by—</text><subparagraph id="id465F997F95FB4FA1A76CBB2878511C1A"><enum>(A)</enum><text>assessing the need for English as a second language instruction;</text></subparagraph><subparagraph id="idA84FBE18D7274427B05C20F9520C8F2B"><enum>(B)</enum><text>conducting educational assessments; and</text></subparagraph><subparagraph id="id76B0256CD2C14569BAA63F898A90E466"><enum>(C)</enum><text>assessing occupational interests and aptitudes;</text></subparagraph></paragraph><paragraph id="id0dedf58a99d342199978ac0491f525c1"><enum>(2)</enum><text>target educational services to assessed needs, including academic and occupational at the basic,
secondary, or post-secondary level;</text></paragraph><paragraph id="id1b4eed07c2b14a7999767cbc55ff12e8"><enum>(3)</enum><text>target career technology education programs to—</text><subparagraph id="id03A3C1A65A4746A281EEBD3E8E52CF86"><enum>(A)</enum><text>areas of identified occupational demand; and</text></subparagraph><subparagraph id="idFFEB598430914E8F98EB12337317F134"><enum>(B)</enum><text>employment opportunities in the communities in which students are
reasonably expected to reside post-release;</text></subparagraph></paragraph><paragraph id="id52e3551678cf43b2bf2e8eec191e976d"><enum>(4)</enum><text>include a range of appropriate educational opportunities at the basic,
secondary, and post-secondary
levels;</text></paragraph><paragraph id="id84e3e90065e94ff2abcf2da996699b0d"><enum>(5)</enum><text>include opportunities for students to attain industry recognized credentials;</text></paragraph><paragraph id="id9a11714ef4b64a0087efd9715e97cc81"><enum>(6)</enum><text>include partnership or articulation agreements linking institutional education programs with
community sited programs provided by adult education program providers and
accredited institutions of higher education, community colleges, and
vocational training institutions; and</text></paragraph><paragraph id="id62e0f4a3019246de9ffebddeede3613a"><enum>(7)</enum><text>explicitly include career pathways models offering opportunities for incarcerated students to
develop academic skills, in-demand occupational skills and credentials,
occupational experience in institutional work programs or work release
programs, and linkages with employers in the community, so that
incarcerated students have opportunities to embark on careers with strong
prospects for both post-release employment and advancement in a career
ladder over time.</text></paragraph></subsection><subsection id="id11115aeea1444e4abe98088d33e485ef"><enum>(e)</enum><header>Requirements</header><text>An eligible entity desiring a grant under this section shall—</text><paragraph id="id20c0aa7179054f909004e85868c08a5d"><enum>(1)</enum><text>describe the evidence-based methodology and outcome measurements that will be used to evaluate each
program funded with a grant under this section, and specifically explain
how such measurements will provide valid measures of the impact of the
program;
and</text></paragraph><paragraph id="id16a84d98f4254834b3230e8ef138c107"><enum>(2)</enum><text>describe how the program described in paragraph (1) could be broadly replicated if demonstrated to
be effective.</text></paragraph></subsection><subsection id="idbf43b7719ba14ce7bd314191cd94f62d"><enum>(f)</enum><header>Control of Internet access</header><text>An entity that receives a grant under this section shall restrict access to the Internet by
prisoners, as appropriate, to ensure public safety.</text></subsection></section><section id="id961256d34d31497e828b4b4ee07f0d0d"><enum>3002.</enum><header>Authorization of appropriations</header><text display-inline="no-display-inline">There are authorized to be appropriated $5,000,000 to carry out this part for fiscal years 2016
through 2020.</text></section></part><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section id="id7145dbc15df64621b7d2e1e546a6d601"><enum>402.</enum><header>Revision of FAFSA form</header><text display-inline="no-display-inline">Section 483 of the Higher Education Act of 1965 (<external-xref legal-doc="usc" parsable-cite="usc/20/1090">20 U.S.C. 1090</external-xref>) is amended by adding at the end
the following:</text><quoted-block display-inline="no-display-inline" id="idb20141cf78a34c44964f46dac845ded3" style="OLC"><subsection id="idd5ddd28c29b248238a9f2bb7f61fcb56"><enum>(i)</enum><header>Convictions</header><text>The Secretary shall not include any question about the conviction of an applicant for the
possession or sale of illegal drugs on the FAFSA (or any other form
developed under subsection
(a)).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section><section id="id281bf5899289453db24fce7238f4768d"><enum>403.</enum><header>National Task Force on Recovery and Collateral Consequences</header><subsection id="id880724bead87403c9f1bb424bc17f85c"><enum>(a)</enum><header>Definition</header><text>In this section, the term <term>collateral consequence</term> means a penalty, disability, or disadvantage—</text><paragraph id="id1bfcae2b73404452b8f1ab52e4cdfde8"><enum>(1)</enum><text>imposed on an individual as a result of a criminal conviction but not as part of the judgment of
the court that imposes the conviction;
or</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="idba9290e8295149d88ab3bcf254fad550"><enum>(2)</enum><text>that an administrative agency, official, or civil court is authorized, but not required, to impose
on an individual convicted of a felony, misdemeanor, or other criminal
offense.</text></paragraph></subsection><subsection id="ida07512dfb1ea428b8d092ab8711bbccc"><enum>(b)</enum><header>Establishment</header><paragraph id="id568fe48cb2dd440fa167a9390e2402c8"><enum>(1)</enum><header>In general</header><text>Not later than 30 days after the date of enactment of this Act, the Secretary of Health and Human
Services
(in this section referred to as the <quote>Secretary</quote>) shall establish a bipartisan task force to be known as the Task Force on Recovery and Collateral
Consequences (in this section referred to as the <quote>Task Force</quote>).</text></paragraph><paragraph id="id4b78a4b37c3a464caa8e829b94926fbb"><enum>(2)</enum><header>Membership</header><subparagraph id="id6aa135d7ef3e4b579aca942967684f20"><enum>(A)</enum><header>Total number of members</header><text>The Task Force shall include 9 members, who shall be appointed by the Secretary in accordance with
subparagraphs (B) and (C).</text></subparagraph><subparagraph id="idb21cae46f08846bcba5aa52eb3eac9f3"><enum>(B)</enum><header>Members of the Task Force</header><text>The Task Force shall include—</text><clause id="idc11a072074d44049b46ab4076c925049"><enum>(i)</enum><text>members who have national recognition and significant expertise in areas such as health care,
housing, employment, substance use disorder, law enforcement, and law;</text></clause><clause id="id5ddd8fdd71a742099fb63528ec79276d"><enum>(ii)</enum><text>not less than 1 member who has personally experienced addiction and is in recovery; and</text></clause><clause id="id439ca9ce0b734d8c9243ed62b9fc855b"><enum>(iii)</enum><text>to the extent practicable, members who formerly served as elected officials at the State and
Federal levels.</text></clause></subparagraph><subparagraph id="idcf5ab5e5b95e4ac8950720a314f6b2be"><enum>(C)</enum><header>Timing</header><text>The Secretary shall appoint the members of the Task Force not later than 60 days after date on
which the Task
Force is established under paragraph (1).</text></subparagraph></paragraph><paragraph id="id67c1477fc9764c3dbfeb129a91c156e4"><enum>(3)</enum><header>Chairperson</header><text>The Task Force shall select a chairperson or co-chairpersons from among the members of the Task
Force.</text></paragraph></subsection><subsection id="id7434bcec64f549acb09429ef41cbf277"><enum>(c)</enum><header>Duties of the Task Force</header><paragraph id="id1bc9b058203f42fe9cb16852f714753b"><enum>(1)</enum><header>In general</header><text>The Task Force shall—</text><subparagraph id="ideb887dc3d5df439fa999f35934e54be9"><enum>(A)</enum><text>identify collateral consequences for individuals with Federal or State drug convictions who are in
recovery for substance use disorder; and</text></subparagraph><subparagraph id="id9bf1c25bbb2e47b0af05fbc41a9eac07"><enum>(B)</enum><text>determine whether the collateral consequences identified under subparagraph (A) unnecessarily delay
individuals in recovery from resuming their personal and professional
activities.</text></subparagraph></paragraph><paragraph id="idb04a2874221f4a12bce78df76fe7f104"><enum>(2)</enum><header>Recommendations</header><text>Not later than 180 days after the date of the first meeting of the Task Force, the Task Force shall
develop recommendations for
proposed legislative and regulatory changes to reduce and, to the extent
practicable, eliminate the collateral consequences identified by the Task
Force under paragraph (1).</text></paragraph><paragraph id="id7b1fd8fe562743cf83d7a1ed55a6724b"><enum>(3)</enum><header>Collection of information</header><text>The Task Force shall hold hearings, require the testimony and attendance of witnesses, and secure
information from any department or agency of the United States in
performing the duties under paragraphs (1) and (2).</text></paragraph><paragraph id="id009f4d0f8f22474a9978165f883955a3"><enum>(4)</enum><header>Report</header><text>Not later than 1 year after the date of the first meeting of the Task Force, the Task Force shall
submit a
report detailing the findings and recommendations of the Task Force to—</text><subparagraph id="id7c6424032d674af3b8d2874f2919ebe1"><enum>(A)</enum><text>each relevant committee of Congress;</text></subparagraph><subparagraph id="id6f9b2f983a164922a35229bf3a933494"><enum>(B)</enum><text>the head of each relevant department or agency of the United States;</text></subparagraph><subparagraph id="idc377e7aefe204b29ae56ce0f9e183f7f"><enum>(C)</enum><text>the President; and</text></subparagraph><subparagraph id="idd85b9997710a4dfdb3f629946d023e23"><enum>(D)</enum><text>the Vice President.</text></subparagraph></paragraph></subsection></section><enum>V</enum><header>Addiction and treatment services for women, families, and veterans</header><section id="id70c5eb86a63a4a0ba472f72e1ec3e850"><enum>501.</enum><header>Authority to award competitive grants to address opioid and heroin abuse by pregnant and parenting
female offenders</header><subsection id="id0e96658a37584a258e7bb7ff9be7b4e0"><enum>(a)</enum><header>Definitions</header><text>In this section—</text><paragraph id="id7F1ABB1A2D96473F959FF82262F758C2"><enum>(1)</enum><text>the term <term>State criminal justice agency</term> means the agency of the State responsible for administering criminal justice funds, including the
Edward Byrne Memorial Justice
Assistance Grant Program under subpart 1 of part E of title I of the
Omnibus Crime Control and Safe Streets Act of 1968 (42 U.S.C. 3750 et
seq.); and</text></paragraph><paragraph id="id60a7913119344cd3b9e131f7ddd81823"><enum>(2)</enum><text>the term <term>State substance abuse agency</term> means the agency of the State responsible for the State prevention, treatment, and
recovery system, including management of the Substance Abuse Prevention
and Treatment Block Grant under subpart II of part B of title XIX of the
Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300x-21">42 U.S.C. 300x–21 et seq.</external-xref>).</text></paragraph></subsection><subsection id="id0cb6028a93144f98aff3f8c58168ac9a"><enum>(b)</enum><header>Purpose and program authority</header><paragraph id="idc9c71d2775774f08884117e7db63d3cb"><enum>(1)</enum><header>Grant authorization</header><text>The Attorney General may award competitive grants jointly to a State substance abuse agency and a
State criminal justice
agency to address the use of opioids and heroin among
pregnant and parenting female offenders in the State to promote public
safety, public
health, family permanence, and well-being.</text></paragraph><paragraph id="idb9dbde07d4e3494b908c68570794594c"><enum>(2)</enum><header>Purposes and program authority</header><text>A grant under this section shall be used to facilitate or enhance collaboration between the
State criminal justice and State substance abuse systems in order to carry
out programs to address the use of opioid and heroin abuse by pregnant and
parenting female offenders.</text></paragraph></subsection><subsection id="idbe0589e55c8c4408a3deb966f01eecd3"><enum>(c)</enum><header>Applications</header><paragraph id="id7ca72f0c3811415fb397f3e439b91353"><enum>(1)</enum><header>In general</header><text>A State substance abuse agency and State criminal justice
agency desiring a grant under this section shall jointly submit to the
Attorney General an application in such form, and containing such
information, as the Attorney General may prescribe by regulation or
guidelines.</text></paragraph><paragraph id="idaa2b2bcbec64432dbd08ee315f3e2057"><enum>(2)</enum><header>Contents</header><subparagraph id="idC557210113694E79AC94690387E622B8"><enum>(A)</enum><header>In general</header><text>Each
application for a grant under this section shall contain a plan to expand
the services of the State for pregnant and parenting female offenders for
the use of
opioids, heroin, and other drugs, which shall be in accordance with
regulations or guidelines established by the Attorney General, in
consultation with the Secretary of Health and Human Services.</text></subparagraph><subparagraph id="idB457D3276AAF43C08E679C177D90EFC6"><enum>(B)</enum><header>Plan</header><text>A plan submitted under subparagraph (A) shall, at a minimum, include—</text><clause id="id41ae39e935914269923b2876f67aad56"><enum>(i)</enum><text>a description of how the applicants will work jointly to address the needs associated with the use
of opioids or heroin by pregnant and parenting female offenders to promote
family stability and permanence;</text></clause><clause id="id826d509d85aa44a484c860ce6bf47c04"><enum>(ii)</enum><text>a description of the nature and the extent of the problem of opioid and heroin use by pregnant and
parenting female offenders in the State;</text></clause><clause id="id80ec8f3847ef4fc5a01cb1ebcdde975c"><enum>(iii)</enum><text>a certification that the State has involved counties and other units of local government, when
appropriate, in the development, expansion, modification, operation, or
improvement of proposed programs to address the problems associated with
opioid and heroin use;</text></clause><clause id="idfed9dbb98f1247b7964d468798c718b2"><enum>(iv)</enum><text>a certification that funds received under this section will be used to supplement, not supplant,
other Federal, State, and local funds; and</text></clause><clause id="idc60afdb51ed243b1b2fe5ea3498165b1"><enum>(v)</enum><text>a description of clinically appropriate practices and procedures to—</text><subclause id="id0e4eb85f3b144873824fe36e6ce0a40b"><enum>(I)</enum><text>screen and assess pregnant and parenting female offenders for problems associated with opioids and
heroin;</text></subclause><subclause id="idc52572ae4e724e7680a7c151ee151c00"><enum>(II)</enum><text>provide clinically appropriate services, including medication assisted treatment, for female
offenders and their children in the same
location to promote family permanence and self-sufficiency; and</text></subclause><subclause id="id3b5a53f8940d4417bab8cd90618a5478"><enum>(III)</enum><text>provide for a process to enhance or ensure the abilities of the State criminal justice agency and
State substance abuse agency to work together to reunite families when
appropriate in the case where family treatment is not provided.</text></subclause></clause></subparagraph></paragraph></subsection><subsection id="id3519ef9c47d64a90b6883d7c66c5c315"><enum>(d)</enum><header>Period of grant; renewal</header><paragraph id="idB8F10AA665A041C1A8DDF49EA5CC4075"><enum>(1)</enum><header>Period</header><text>A grant under this section shall be for a period of 3 years.</text></paragraph><paragraph id="id791397B9F7C846F1A56C2580A9C85CCB"><enum>(2)</enum><header>Renewal</header><text>A State substance abuse agency and a State criminal justice
agency receiving a grant under this section may apply for and, after the
end of the period of the first grant under this section, receive 1
additional grant under this section.</text></paragraph></subsection><subsection id="id9a6c2c8f72dd4d69b64f883fdcbcaaf7"><enum>(e)</enum><header>Performance accountability; reports</header><paragraph id="idedc5c7a9753440d49346aff075b07e74"><enum>(1)</enum><header>Reports</header><text>A State substance abuse agency and a State criminal justice
agency receiving a grant under this section shall jointly submit to the
Attorney General a report on the activities carried out
under the grant at the end of each fiscal year during the period of the
grant.</text></paragraph><paragraph commented="no" id="id8c8e460310a746f79d33e0e7b9272737"><enum>(2)</enum><header>Evaluation</header><text>Not later than 1 year after the end of the period of a grant under this section, the Attorney
General shall submit a report to each committee of Congress with
jurisdiction of the program under this section that summarizes the reports
of the recipients of the grant and provides recommendations, if any, for
further legislative action.</text></paragraph></subsection><subsection id="id0baafafc1ee646ed82775e9bae595e23"><enum>(f)</enum><header>Training and Technical Assistance</header><text>The Attorney General shall support State substance abuse and State criminal justice agencies by
developing, in consultation with State substance abuse and State criminal
justice agencies, and offering
a program of training and technical assistance to assist the agencies in
developing programs and protocols—</text><paragraph id="id30E23A1ECD3E4741856707080DA3402F"><enum>(1)</enum><text>to
implement this section; and</text></paragraph><paragraph id="id6694A60579D546CDBFDBA8E46E17C66B"><enum>(2)</enum><text>for effectively working across the Federal and State criminal
and substance abuse systems.</text></paragraph></subsection><subsection id="id07d931bd9e494fc482eb9bd7f55e8515"><enum>(g)</enum><header>Authorization of Appropriations</header><text>There are authorized to be appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.</text></subsection></section><section id="idd18dc0f398ee4ea0adf67a54f80e29e5"><enum>502.</enum><header>Grants for family-based substance abuse treatment</header><text display-inline="no-display-inline">Section 2925 of the Omnibus Crime Control and Safe Streets Act of 1968 (<external-xref legal-doc="usc" parsable-cite="usc/42/3797s-4">42 U.S.C. 3797s–4</external-xref>) is
amended—</text><paragraph id="id889b3a9fce9a42a6ae0e149a8a047cc2"><enum>(1)</enum><text>by striking <quote>An entity</quote> and inserting <quote>(a) <header-in-text level="subsection" style="OLC">Entity Reports</header-in-text>.—An entity</quote>; and</text></paragraph><paragraph id="id2a4e7ed2b6fb4c90b38deb1690af01d9"><enum>(2)</enum><text>by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="idfee0ac4c339f43ca946fa63e091227d9" style="OLC"><subsection id="idc2f17e5e87504d5b980e59d1d565bbcb"><enum>(b)</enum><header>Attorney general report on family-Based substance abuse treatment</header><text>The Attorney General shall submit to Congress an annual report that describes the number of grants
awarded under section 2921(1) and how such grants are used by the
recipients for family-based substance
abuse treatment programs that serve as alternatives to incarceration for
custodial parents to receive treatment and services as a family.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section id="id5E88EA843A034739AE04A0124F576425"><enum>503.</enum><header>Veterans' treatment courts</header><text display-inline="no-display-inline">Section 2991 of the Omnibus Crime Control and Safe Streets Act of 1968 (<external-xref legal-doc="usc" parsable-cite="usc/42/3797aa">42 U.S.C. 3797aa</external-xref>) is
amended—</text><paragraph id="idCA923A3482A24253860324A75FAE26AD"><enum>(1)</enum><text display-inline="yes-display-inline">by redesignating subsection (i) as subsection (j);</text></paragraph><paragraph id="id521da76a703b401783d98923f14e27b2"><enum>(2)</enum><text>by inserting after subsection (h) the following:</text><quoted-block display-inline="no-display-inline" id="id91D8AC24CBBB4742BAE5C7227CE01C65" style="OLC"><subsection id="id3ed368f7f09a4147892711e01b7db0bd"><enum>(i)</enum><header>Assisting veterans</header><paragraph id="id0e722cbc3bb640a5afe2c97888ab17b6"><enum>(1)</enum><header>Definitions</header><text>In this subsection:</text><subparagraph id="idf9a3f5717a9043509032d96fb29166d3"><enum>(A)</enum><header>Peer to peer services or programs</header><text>The term <term>peer to peer services or programs</term> means services or programs that connect qualified veterans with other veterans for the purpose of
providing support and mentorship to assist qualified veterans in obtaining
treatment, recovery, stabilization, or rehabilitation.</text></subparagraph><subparagraph id="id1f3ec549ede841cb9d76ab14017af7c3"><enum>(B)</enum><header>Qualified veteran</header><text>The term <term>qualified veteran</term> means a preliminarily qualified offender who—</text><clause id="id496b155bf2c74f08bb16e9a4e45924be"><enum>(i)</enum><text>has served on active duty in any branch of the Armed Forces, including the National Guard and
reserve components; and</text></clause><clause id="id0e968c94a6be4524ae522a25cd4d6122"><enum>(ii)</enum><text>was discharged or released from such service under conditions other than dishonorable.</text></clause></subparagraph><subparagraph id="idd23c29a0a26d45d587ce935565aeb170"><enum>(C)</enum><header>Veterans treatment court program</header><text>The term <term>veterans treatment court program</term> means a court program involving collaboration among criminal justice, veterans, and mental health
and substance abuse agencies that provides qualified veterans with—</text><clause id="ide6138303f57740e38a91b290f5f223ce"><enum>(i)</enum><text>intensive judicial supervision and case management, which may include random and frequent drug
testing where appropriate;</text></clause><clause id="idf128a84971f9417a93dc8db078472771"><enum>(ii)</enum><text>a full continuum of treatment services, including mental health services, substance abuse services,
medical services, and services to address trauma;</text></clause><clause id="id31490170a63a4c358f0f1023f460cf2f"><enum>(iii)</enum><text>alternatives to incarceration; and</text></clause><clause id="id80a346a4a1b44446b0f7b8c434f9ef0d"><enum>(iv)</enum><text>other appropriate services, including housing, transportation, mentoring, employment, job
training, education, and assistance in applying for and
obtaining available benefits.</text></clause></subparagraph></paragraph><paragraph id="id1a3a6bc12724405cbf8f814764bff52a"><enum>(2)</enum><header>Veterans assistance program</header><subparagraph id="idd8131394e9674656adf908edfdcc8971"><enum>(A)</enum><header>In general</header><text>The Attorney General, in consultation with the Secretary of Veterans Affairs, may award grants
under this subsection to applicants to establish or expand—</text><clause id="idfb227712f752483c8b86adc75f25ad8a"><enum>(i)</enum><text>veterans treatment court programs;</text></clause><clause id="ide8c4bf06b0a94224a7b84961acfe9f93"><enum>(ii)</enum><text>peer to peer services or programs for qualified veterans;</text></clause><clause id="idaf1f63db47cc492897383cd039cb0c0c"><enum>(iii)</enum><text>practices that identify and provide treatment, rehabilitation, legal, transitional, and other
appropriate services to qualified veterans who have been incarcerated; and</text></clause><clause id="idee23ddbb8d6848909361145b1c77f7cf"><enum>(iv)</enum><text>training programs to teach criminal justice, law enforcement, corrections, mental health, and
substance abuse personnel how to identify and appropriately respond to
incidents involving qualified veterans.</text></clause></subparagraph><subparagraph id="id741699b38f814bf8b92aa2e63c0da49a"><enum>(B)</enum><header>Priority</header><text>In awarding grants under this subsection, the Attorney General shall give priority to applications
that—</text><clause id="idcfa2a2d2691e42a4987f9e7e84c4c61a"><enum>(i)</enum><text>demonstrate collaboration between and joint investments by criminal justice, mental health,
substance abuse, and veterans service agencies;</text></clause><clause id="id7b3e4efe99514787a78b547aac4bc66f"><enum>(ii)</enum><text>promote effective strategies to identify and reduce the risk of harm to qualified veterans and
public safety; and</text></clause><clause id="id62fdf337e951439badada43f409ef5c4"><enum>(iii)</enum><text>propose interventions with empirical support to improve outcomes for qualified veterans.</text></clause></subparagraph></paragraph></subsection><after-quoted-block>; and</after-quoted-block></quoted-block></paragraph><paragraph id="id716F3BAE45EA44E7BE690D463730BD9E"><enum>(3)</enum><text>in subsection (j), as so redesignated—</text><subparagraph id="idF1A14D9C278549B59FD86B27A463C0A3"><enum>(A)</enum><text>by redesignating paragraph (2) as paragraph (3); and</text></subparagraph><subparagraph id="idA415DC6AF0AD44388688F7BE720D737C"><enum>(B)</enum><text>by inserting after paragraph (1) the following:</text><quoted-block display-inline="no-display-inline" id="id2ADB193A3445444DBB6B7DE6A8247B41" style="OLC"><paragraph id="idE265FBA6842541D2B98711CEFB5F7E80"><enum>(2)</enum><header>Veterans treatment courts</header><text>In addition to the amounts authorized under paragraph (1), there are authorized to be appropriated
to the Attorney General $5,000,000 for each of fiscal years 2016 through
2020 to carry out subsection (i).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></section><enum>VI</enum><header>Incentivizing State comprehensive initiatives to address opioid and heroin abuse</header><section id="id88adb36ad4ef44d581d38dce24e1a49f"><enum>601.</enum><header>State demonstration grants for comprehensive opioid abuse response</header><subsection id="id86178425d92d45698e6f4ed915fd815a"><enum>(a)</enum><header>Definitions</header><text>In this section—</text><paragraph id="iddae79442457546c5a4de03164e490e56"><enum>(1)</enum><text>the term <term>civil liability protection law</term> means a State law that protects from civil liability individuals who give aid on a voluntary basis
in an emergency to individuals who are ill, in peril, or otherwise
incapacitated;</text></paragraph><paragraph id="id05276d137eac4cf48c96b55a74dd6af9"><enum>(2)</enum><text>the term <term>dispenser</term> has the meaning given the term in section 102 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802</external-xref>);</text></paragraph><paragraph id="ide47f4f2e2405432b9cb7b5aecec648d8"><enum>(3)</enum><text>the term <term>prescriber of a schedule II, III, or IV controlled substance</term> does not include a prescriber of a schedule II, III, or IV controlled substance that dispenses the
substance—</text><subparagraph id="id4ada15ff2ba446c5b1f3afe6428dc4dc"><enum>(A)</enum><text>for use on the premises on which the substance is dispensed;</text></subparagraph><subparagraph id="ide544c256b6cc4deca356a98c3bd8257f"><enum>(B)</enum><text>in a hospital emergency room, when the substance is in short supply;</text></subparagraph><subparagraph id="id18b957078c77444dbbaea518fd91df84"><enum>(C)</enum><text>for a certified opioid treatment program; or</text></subparagraph><subparagraph id="id600e3d26ceef42f8af81754e8279769f"><enum>(D)</enum><text>in other situations as the Attorney General may reasonably determine;</text></subparagraph></paragraph><paragraph id="ida5d8c6a0f9084485bad5ac33a5ac48a0"><enum>(4)</enum><text>the term <term>prescriber</term> means a dispenser who prescribes a controlled substance, or the agent of such a dispenser; and</text></paragraph><paragraph id="id0481d98bc98a4168a6b6e9361409f8ae"><enum>(5)</enum><text>the term <term>schedule II, III, or IV controlled substance</term> means a controlled substance that is listed on schedule II, schedule III, or schedule IV of
section 202(c) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/812">21 U.S.C. 812(c)</external-xref>).</text></paragraph></subsection><subsection id="id87e17d2722764f2c8c0387ff8035a5ee"><enum>(b)</enum><header>Planning and implementation grants</header><paragraph id="id8b165917bd064c98b856904d8ca9df8f"><enum>(1)</enum><header>In general</header><text>The Attorney General, in coordination with the Secretary of Health and Human Services and the
Director of the Office of National Drug Control Policy, may award grants
to States, and combinations thereof, to prepare a comprehensive plan
for and implement an integrated opioid abuse response initiative.</text></paragraph><paragraph id="id86e0f0b17fe44ea99c1c18686b107fcc"><enum>(2)</enum><header>Purposes</header><text>A State receiving a grant under this section shall establish a comprehensive response to opioid
abuse, which shall include—</text><subparagraph id="id4b97644dd21a44c6b27b6d5215cbd6d5"><enum>(A)</enum><text>prevention and education efforts around heroin and opioid use, treatment, and recovery;</text></subparagraph><subparagraph id="idc69c821ce90740919ecffdf840f443b9"><enum>(B)</enum><text>a comprehensive prescription
drug monitoring program to track dispensing of schedule II, III, or IV
controlled substances, which shall include—</text><clause id="id0cbda06df51a44b290bf8c686d298e80"><enum>(i)</enum><text>data sharing with other States by statute, regulation, or interstate agreement;</text></clause><clause id="id47a9c45a085f412eae909811eb35f4f1"><enum>(ii)</enum><text>educating physicians, residents, medical students, and other prescribers of Schedule II, III, or IV
controlled substances on the prescription drug
monitoring program of the State;</text></clause></subparagraph><subparagraph id="idfad55cb6417b4753920c20c2e1f6f5fe"><enum>(C)</enum><text>developing, implementing, or expanding the prescription drug and opioid addiction treatment
program of the State by—</text><clause id="id1c30dba244d24f0a9e86e7a4d9d88e1f"><enum>(i)</enum><text>expanding programs for medication assisted treatment of prescription drug and opioid addiction,
including training for treatment and recovery support providers;</text></clause><clause id="id6bbc1ad641af4b859cbafca61aa69ca8"><enum>(ii)</enum><text>developing, implementing, or expanding programs for behavioral health therapy for individuals who
are in
treatment for prescription drug and opioid addiction, including
contingency management, cognitive behavioral therapy, and motivational
enhancements; or</text></clause><clause id="id2e02d284688a4c76b532817231876b8d"><enum>(iii)</enum><text>developing, implementing, or expanding programs to screen individuals who are in treatment for
prescription
drug and opioid addiction for hepatitis C and HIV, and provide treatment
for those individuals if clinically appropriate; and</text></clause></subparagraph><subparagraph id="id49105e92bac2409e849a79ec9bdfc9ae"><enum>(D)</enum><text>developing, implementing, and expanding programs to prevent overdose death of prescription
medications and
opioids.</text></subparagraph></paragraph><paragraph id="id6257ca9536854f5a8dd72ae05b540ab4"><enum>(3)</enum><header>Planning grant applications</header><subparagraph id="id9945f900da654e239d27a1d6ab824a6d"><enum>(A)</enum><header>Application</header><clause id="id691A7DB131B641D996E8EA4CB75B1285"><enum>(i)</enum><header>In general</header><text>A State desiring a planning grant under this section to prepare a comprehensive plan
for an integrated opioid abuse response initiative shall submit to the
Attorney General an application in such form, and containing such
information, as the Attorney General may prescribe by regulation or
guidelines.</text></clause><clause id="id11e0ebdcb85c40219366c7aca3e79858"><enum>(ii)</enum><header>Requirements</header><text>An application for
a planning grant under this section shall, at a minimum, include—</text><subclause id="id980C23A358FE46B7BAD89DB440274F83"><enum>(I)</enum><text>a budget and a budget
justification for the activities to be carried out using the grant;</text></subclause><subclause id="id581B5F20B6B145D1B34581D3D0B56B03"><enum>(II)</enum><text>a description of the activities proposed to be carried out using the grant, including a schedule
for completion of such
activities;</text></subclause><subclause id="id53411730B4894B1CA3AED1F1AB13A54D"><enum>(III)</enum><text>outcome measures that will be used to
measure the effectiveness of the programs and initiatives to address
opioids; and</text></subclause><subclause id="id6F396471F3F34E63843487000940241E"><enum>(IV)</enum><text>a description of the personnel necessary to complete such activities.</text></subclause></clause></subparagraph><subparagraph id="id8a2b927ffec64d89bb8f4b467a6a14bd"><enum>(B)</enum><header>Period; nonrenewability</header><text>A planning grant under this section shall be for a period of 1 year. A State may not receive more
than 1
planning grant under this section.</text></subparagraph><subparagraph id="idbb8a967ef6bf44739ddfec9f377f2d1c"><enum>(C)</enum><header>Amount</header><text>A planning grant under this section may not exceed $100,000, except that the Attorney General may,
for
good cause, approve a grant in a higher amount.</text></subparagraph><subparagraph id="id638A5E46D1E74856B37B4F1308AD8293"><enum>(D)</enum><header>Strategic plan and program implementation plan</header><text>A State receiving a planning grant under this section shall develop a strategic plan and a program
implementation plan.</text></subparagraph></paragraph><paragraph id="id510b3c16f7ee40c6898e34e5c3fa47cc"><enum>(4)</enum><header>Implementation grants</header><subparagraph id="id23ff8b8a2b274812ae9efae92fb1c26b"><enum>(A)</enum><header>Application</header><text>A State desiring an implementation grant under this section to implement a comprehensive strategy
for addressing opioid abuse shall submit to the Attorney General an
application in such form, and containing such
information, as the Attorney General may prescribe by regulation or
guidelines.</text></subparagraph><subparagraph id="id59c1c5b4fd3f49f8912b4959d28e1aab"><enum>(B)</enum><header>Use of funds</header><text>A State that receives an implementation grant under this section shall use the grant for the cost
of carrying out an integrated opioid abuse
response program in accordance with this section, including for technical
assistance, training, and
administrative expenses.</text></subparagraph><subparagraph commented="no" id="idbcc3fe6e13714f0b8e892b8614fda789"><enum>(C)</enum><header>Requirements</header><text>An integrated opioid abuse response program carried out using an implementation grant under this
section shall—</text><clause commented="no" id="ideea82396b68f4215b76dce23914320cb"><enum>(i)</enum><text>ensure that each prescriber of a schedule II, III, or IV controlled substance in the State—</text><subclause commented="no" id="idc7e3459345a54effaf1486a1f8b2a5ad"><enum>(I)</enum><text>registers with the prescription drug monitoring program of the State; and</text></subclause><subclause commented="no" id="id4330306180864360828823b9a899af2e"><enum>(II)</enum><text>consults the prescription drug monitoring program database of the State before prescribing a
schedule II, III, or IV controlled substance;</text></subclause></clause><clause commented="no" id="id38233173ae7749c4a495da557ec9624e"><enum>(ii)</enum><text>ensure that each dispenser of a schedule II, III, or IV controlled substance in the State—</text><subclause commented="no" id="id06e376c3fffa4ceaabdc84265cd6f348"><enum>(I)</enum><text>registers with the prescription drug monitoring program of the State;</text></subclause><subclause commented="no" id="idb5e01fd28ce0460191d3ee8a410c91b2"><enum>(II)</enum><text>consults the prescription drug monitoring program database of the State before dispensing a
schedule II, III, or IV controlled substance; and</text></subclause><subclause id="idcb182ee71b8a4c698cb3711219d8d813"><enum>(III)</enum><text>reports to the prescription drug monitoring program of the State, at a minimum, each instance in
which a schedule II, III, or IV controlled substance is dispensed, with
limited exceptions, as defined by the State, which shall indicate the
prescriber by name and National Provider Identifier;</text></subclause></clause><clause commented="no" id="id75c1250029fc467185ba81adb47defc5"><enum>(iii)</enum><text>require that, not fewer than 4 times each year, the State agency or agencies that administer the
prescription drug monitoring program of the State prepare and provide to
each prescriber of a schedule II, III, or IV controlled substance an
informational report that shows how the prescribing patterns of the
prescriber compare to prescribing practices of the peers of the prescriber
and
expected norms;</text></clause><clause commented="no" id="id823dd06560ca4306a02a905a2203391f"><enum>(iv)</enum><text>if informational reports provided to a prescriber under clause (iii) indicate that the prescriber
is repeatedly falling outside of expected norms, direct the prescriber to
educational resources on appropriate prescribing of controlled substances;</text></clause><clause commented="no" id="id700291ae553c43f0934a8363fb6b548f"><enum>(v)</enum><text>ensure that the prescriber licensing board of the
State receives a report describing any prescribers that repeatedly fall
outside of expected norms, as described in clause (iii);</text></clause><clause commented="no" id="iddce0b4f5f81442a09518ef91f31d0378"><enum>(vi)</enum><text>require consultation with the Single State Authority for Substance Abuse; and</text></clause><clause commented="no" id="id95bef2ed332c47a1a942c37b527bfbeb"><enum>(vii)</enum><text>establish requirements for how data will be collected and analyzed to determine the effectiveness
of the program.</text></clause></subparagraph><subparagraph id="id2e136e4b8b7448b8bfbce463961eb79d"><enum>(D)</enum><header>Period</header><text>An implementation grant under this section shall be for a period of 2 years.</text></subparagraph><subparagraph id="id0f3b4d250b1a44a2b71adcae58934852"><enum>(E)</enum><header>Amount</header><text>The amount of an implementation grant under this section may not exceed $5,000,000 except that the
Attorney General
may, for good cause, approve a grant in a higher amount.</text></subparagraph></paragraph><paragraph id="idaac8f11fba5b445eafe18f32e1639f7c"><enum>(5)</enum><header>Priority considerations</header><text>In awarding planning and implementation grants under this section, the Attorney General shall give
priority to a State that—</text><subparagraph commented="no" id="idb31bb4d189f7410183c6c98f8b13a582"><enum>(A)</enum><text>provides civil liability protection for first responders, health professionals, and family members
administering naloxone to counteract opioid overdoses by—</text><clause commented="no" id="ida821546437264870920866b756daf4f7"><enum>(i)</enum><text>enacting legislation that provides such civil liability protection; or</text></clause><clause commented="no" id="id30e428f184d240d3ac8479189a4e8567"><enum>(ii)</enum><text>providing a certification by the attorney general of the State that the attorney general has—</text><subclause commented="no" id="id35512e1c94584601b256157a7ea8108e"><enum>(I)</enum><text>reviewed any applicable civil liability protection law to determine the applicability of the law
with respect to first responders, health care professionals, family
members, and other individuals who may administer naloxone to individuals
reasonably believed to be suffering from opioid overdose; and</text></subclause><subclause commented="no" id="idc45026c3aba643eb89097ef90bd788cd"><enum>(II)</enum><text>concluded that the law described in subclause (I) provides adequate civil liability protection
applicable to such persons;</text></subclause></clause></subparagraph><subparagraph commented="no" id="idbcfa3d47661e4481a3c34d63f27979b1"><enum>(B)</enum><text>have in effect legislation or implement a policy under which the State shall not terminate, but may
suspend,
enrollment under the State plan for medical assistance under title XIX of
the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396">42 U.S.C. 1396 et seq.</external-xref>) for an individual who is
incarcerated for a period of fewer than 2 years;</text></subparagraph><subparagraph commented="no" id="id9037323df3b94c2d96c7c42c567cc343"><enum>(C)</enum><text>have a process for enrollment in services and benefits necessary by criminal justice agencies
to initiate or continue treatment in the community, under which an
individual who is incarcerated may, while incarcerated, enroll in services
and benefits that are necessary for the individual to continue treatment
upon release from incarceration;</text></subparagraph><subparagraph commented="no" id="id3c02a20db16a4db39627af0062ed5095"><enum>(D)</enum><text>ensures the capability of data sharing with other States, such as by making data available to a
prescription monitoring hub;</text></subparagraph><subparagraph commented="no" id="id3e25f57c7ff948d7a794a4c5597f39ba"><enum>(E)</enum><text>ensures that data recorded in the prescription drug monitoring program database of the State is
available within 24 hours, to the extent possible; and</text></subparagraph><subparagraph commented="no" id="id0a6fb89ccb0144ac92ad49a4705a202b"><enum>(F)</enum><text>ensures that the prescription drug monitoring program of the State notifies prescribers and
dispensers of schedule II, III, or IV controlled substances when overuse
or misuse of such controlled substances by patients is suspected.</text></subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="idd5df3157cd3c4173994ac4368d4e5099"><enum>(c)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $15,000,000 for each of fiscal
years 2016 through 2020.</text></subsection></section>